Podcasts about accessed may

Episode 95 celebrates all things Westmoot, the American gathering of the Tolkien Society held from May 22-24, 2026 in Minneapolis, Minnesota! We begin with a reflection on our experience at Westmoot. Then we present our live show from Westmoot, “Disasters, Downfalls, and Dives: Athrabeth Podcast Live” with special guests Clare Moore and Tori Owens. We each chose our favorite disaster to present to the listeners: Daeron, Finrod, Saeros, and Túrin.   Citations Thank you to our guests, Clare Moore and Tori Owens!   Clare can be found on Bsky at @clarelmoore.bsky.social The Big Read dates and information can be found here:  https://erikjampa.substack.com/p/tolkien-society-seminar-and-tolkien?utm_source=publication-search (Accessed May 30, 2026) Learn more about the upcoming volume More Perilous and Fair, with Cami Agan, Clare Moore Dr. Robin A. Reid: https://dc.swosu.edu/cgi/viewcontent.cgi?article=1081&context=mythpro (Accessed May 30, 2026)   Tori can be found on instagram @_toriello, and on Bsky @itstoriello.bsky.social   The Sillymarillion podcast can be found at: https://podcasts.apple.com/us/podcast/the-sillymarillion/id1571617612 https://creators.spotify.com/pod/profile/thesillymarillion/ On Instagram at @sillymarillions On Bsky at @thesillymarillion.bsky.social   Join the Athrabeth Discord!  https://discord.gg/4rZynfWv3f

A rising young sitcom star with a bright future ahead of her is gunned down at her own front door, sending shockwaves through Hollywood and beyond. What began as harmless fan mail slowly spiraled into a terrifying obsession that exposed just how vulnerable celebrities could be behind the scenes. In this episode, we unravel the tragic story of Rebecca Schaeffer, the warning signs that were missed, and the case that would forever change stalking laws in America. Sources:  Silverman, Leah, “Inside Rebecca Schaeffer's Murder At The Hands Of Her Stalker”, All Thats Interesting, December 29, 2023, https://allthatsinteresting.com/rebecca-schaeffer, Accessed May 28, 2026   Gurley, Alex, “Rebecca Schaeffer Was Preparing to Audition for Francis Ford Coppola When an Obsessed Fan Killed Her. Inside the Chilling Crime”, People, July 18, 2025, https://people.com/rebecca-schaeffer-death-everything-to-know-11766223, Accessed May 28, 2026  Mehrotra, Kriti, “Rebecca Schaeffer Murder: How Did She Die? Who Killed Her?”, The Cinemaholic, August 20, 2021, https://thecinemaholic.com/rebecca-schaeffer-murder-how-did-she-die-who-killed-her/, Accessed May 28, 2026  

Contributor: Aaron Lessen, MD Educational Pearls:  Back pain is a common presenting complaint in the emergency department. Challenges arise when tailoring care to elderly populations using standard medical therapy: Muscle relaxants carry the risk of CNS depression or anticholinergic effects such as urinary retention and confusion. Pain medications such as opiates have side effects including constipation, respiratory depression, and hypotension. NSAIDs carry a risk of GI bleeding and worsening kidney function with chronic use. A randomized clinical trial assessing the effects of acupuncture on low back pain took 800 adults aged 65 and older with chronic low back pain and placed them into one of three treatment arms: Usual medical care Standard acupuncture consisting of 8–15 treatment sessions over 12 weeks, plus usual medical care Standard acupuncture consisting of 8–15 treatment sessions over 12 weeks, plus 4-6 maintenance sessions during the next 12 weeks, plus usual medical care Using the Roland-Morris Disability Questionnaire (RMDQ) score, they assessed disability at 6 months and 12 months. The study found that those who had undergone treatment with acupuncture had significantly greater improvements in disability related to low back pain compared to the group that was only treated with usual medical care. Acupuncture is not used in the ER, but could represent a relatively safe adjunctive therapy for patients who are not responding to standard medical therapy alone.   References:  American College of Surgeons Committee on Trauma. Best practices guidelines: geriatric trauma management. American College of Surgeons; 2023. Accessed May 27, 2026. https://www.facs.org/media/ubyj2ubl/best-practices-guidelines-geriatric-trauma.pdf DeBar LL, Wellman RD, Justice M, et al. Acupuncture for chronic low back pain in older adults: a randomized clinical trial. JAMA Netw Open. 2025;8(9):e2531348. doi:10.1001/jamanetworkopen.2025.31348 Summarized by Ashley Lyons, OMS3 | Edited by Ashley Lyons & Ahmed Abdel-Hafiz, NREMT-P

Contributor: Travis Barlock, MD Educational Pearls:   Caffeine Geography and Types: Caffeine is found throughout the world and has evolved independently in various plants that are not evolutionarily related through direct lineage, but rather demonstrate convergent evolution (i.e. different species evolve the same traits).  These plants use caffeine as an insecticide.  Examples of caffeine sources include coffee, tea, yerba-mate, guaraná, cacao, and yaupon holly. Roughly 85% of Americans are estimated to consume caffeine daily.   Caffeine Pharmacology in Humans:  In humans, caffeine is a nonselective competitive antagonist (blocker) of adenosine receptors (A1 and A2A).  During waking hours, neuronal metabolic activity consumes ATP, and a byproduct of ATP hydrolysis is created: adenosine.  Adenosine proceeds to build a "sleep pressure".  Acting on A1 and A2A adenosine receptors to induce sleep (on A1, it suppresses neuronal "wakefulness" and on A2A it is believed to be an inducer of sleep).  Caffeine, by blocking those receptors, blunts sleep induction and feelings of being tired.  Caffeine has a half-life of around 6 hours, and a quarter life of approximately 12 hours, which is when the caffeine will off-load and adenosine can once again occupy those receptors, potentially causing a "crash".  Thus, for shift-workers, it is important to time caffeine intake roughly 10 hours before target bed time.  Caffeine exerts other effects on the body.  It is methylxanthine similar to theophylline, which works as a bronchodilator (via phosphodiesterase and adenosine pathways). Caffeine has clinical use to promote bronchodilation in pre-term infants.  Caffeine exerts diuretic effects as well (blocking proximal renal tubule reabsorption).  Recent ingestion of caffeine may blunt therapeutic use of adenosine in patients with SVT.  Key Takeaway? Caffeine exerts a wide variety of effects beyond making us feel more awake. It has cardiovascular, pulmonary, and renal implications in its pharmacodynamics.   References    Benarroch EE. Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease. Neurology. 2008;70(3):231-236. doi:10.1212/01.wnl.0000297939.18236.ec Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ. Beverage caffeine intakes in the U.S. Food Chem Toxicol. 2014;63:136-142. doi:10.1016/j.fct.2013.10.042 Bruschettini M, Brattström P, Russo C, Onland W, Davis PG, Soll R. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity - Bruschettini, M - 2023 | Cochrane Library. Accessed May 23, 2026. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013873.pub2/full?cookiesEnabled Huang R, O'Donnell AJ, Barboline JJ, Barkman TJ. Convergent evolution of caffeine in plants by co-option of exapted ancestral enzymes. Proc Natl Acad Sci U S A. 2016;113(38):10613-10618. doi:10.1073/pnas.1602575113 Cabalag MS, Taylor DM, Knott JC, Buntine P, Smit D, Meyer A. Recent caffeine ingestion reduces adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia. Acad Emerg Med. 2010;17(1):44-49. doi:10.1111/j.1553-2712.2009.00616.x  Summarized by Dan Orbidan, OMS2 | Edited by Dan Orbidan & Ahmed Abdel-Hafiz, NREMT-P   Donate: https://emergencymedicalminute.org/donate/   Join our mailing list: http://eepurl.com/c9ouHf  

In a cobranded episode between Oncology on the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)'s program ASTCT Talks, Mitchell E. Horwitz, MD, highlighted key developments and ongoing initiatives related to allogeneic and cord blood transplantations among patients with different hematologic malignancies. The conversation touched upon the impact of omidubicel-onlv (Omisirge) on patient outcomes, current research on reducing the risk of graft-versus-host disease (GVHD) among transplantation recipients, and strategies for providing effective prophylaxis during treatment, among other topics. According to Horwitz, omidubicel has served as an “important graft source” for pediatric patients while improving cord blood transplantation for adults since its FDA approval in April 2023 for patients 12 years and older with hematologic malignancies. He also spoke to the importance of the FDA's approval of the agent in December 2025 for patients with severe aplastic anemia and no compatible donors following reduced intensity conditioning. Regarding those with severe aplastic anemia, he noted that omidubicel may considerably improve the feasibility of cord blood as a graft source for transplantation.Beyond these approvals, Horwitz described ongoing work dedicated to reducing the risk of GVHD following cord blood-derived transplantation, citing a pilot study that he and colleagues are conducting to determine the feasibility of adding a co-stimulatory blocking monoclonal antibody to help further limit this risk. Additionally, he emphasized surveilling for viruses like Epstein-Barr virus, HHV-6, and cytomegalovirus to mitigate the risks of delayed immune recovery following transplantation.“It's important to have all these [graft sources], whether it be cord blood, mismatched family members, mismatched unrelated donors, and matched siblings…to be made available [and] studied extensively,” Horwitz concluded. “We need to find what the best niche would be for each of these graft sources and make sure that [they] are utilized at the various institutions. The nuances, such as infection prophylaxis or infection monitoring, [should become] familiar to the transplant centers. By doing that, we can continue this trend of having a graft source for everyone and improving outcomes.”Horwitz is a professor of Medicine, Hematologic Malignancies and Cellular Therapy at Duke University School of Medicine and cellular therapy and stem cell specialist at Duke Cancer Institute.References FDA approves cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation. News release. FDA. April 17, 2023. Accessed May 20, 2026. bit.ly/3UEO3kp FDA approves first cellular therapy to treat patients with severe aplastic anemia. News release. FDA. December 8, 2025. Accessed May 20, 2026. https://tinyurl.com/yuu377yt

George Jacobs was executed on August 19th 1692, but his story doesn't end there. What happens after his execution is almost more important that what led him to the gallows. Join Jeffrey and Sarah, your favorite Salem tour guides, as they explore why George Jacobs' legacy after his death is arguably more historically important than how, and why, he died. We examine his altered will, the return of his son, the recanted accusations of his granddaughter, and petitions to the courts. But we also have his remains. George Jacobs is the only victim in the Salem Witch Trials whose burial site is known, and it's not even his first burial site! https://www.reddeathmasquerade.com/ “Case Files Referencing George Jacobs Sr.” Salem Witch Trials Documentary Archive and Transcription Project. Accessed May 13, 2026. (salem.lib.virginia.edu) Charles Wentworth Upham, Salem Witchcraft, vol. 2 (Boston: Wiggin and Lunt, 1867), 427. Emerson W. Baker, A Storm of Witchcraft: The Salem Trials and the American Experience (New York: Oxford University Press, 2015), 148. “Examination of George Jacobs Sr.,” in Records of the Salem Witch-Hunt, ed. Bernard Rosenthal (Cambridge: Cambridge University Press, 2009), 251–52. Frances Hill, A Delusion of Satan: The Full Story of the Salem Witch Trials (New York: Da Capo Press, 1997), 203. “George Jacobs Sr. and the Salem Witch Trials.” History of Massachusetts Blog. Accessed May 13, 2026. History of Massachusetts. “George Jacobs Sr. Home Site.” Salem Witch Museum. Accessed May 13, 2026. Salem Witch Museum.   Interested in Salem The Podcast Merch!?  CLICK HERE! Interested in supporting the Podcast? Looking for more Salem content? CLICK HERE! www.salemthepodcast.com NEW INSTAGRAM - @salemthepod Email - hello@salemthepodcast.com   Book a tour with Sarah at Bewitched Historical Tours   www.bewitchedtours.com Book a tour with Jeffrey at Salem Uncovered Tours  www.salemuncoveredtours.com    Intro/Outro Music from Uppbeat: https://uppbeat.io/t/all-good-folks/unfamiliar-faces License code: NGSBY7LA1HTVAUJE

George Jacobs was executed on August 19th 1692, but his story doesn't end there. What happens after his execution is almost more important that what led him to the gallows. Join Jeffrey and Sarah, your favorite Salem tour guides, as they explore why George Jacobs' legacy after his death is arguably more historically important than how, and why, he died. We examine his altered will, the return of his son, the recanted accusations of his granddaughter, and petitions to the courts. But we also have his remains. George Jacobs is the only victim in the Salem Witch Trials whose burial site is known, and it's not even his first burial site! https://www.reddeathmasquerade.com/ “Case Files Referencing George Jacobs Sr.” Salem Witch Trials Documentary Archive and Transcription Project. Accessed May 13, 2026. (salem.lib.virginia.edu) Charles Wentworth Upham, Salem Witchcraft, vol. 2 (Boston: Wiggin and Lunt, 1867), 427. Emerson W. Baker, A Storm of Witchcraft: The Salem Trials and the American Experience (New York: Oxford University Press, 2015), 148. “Examination of George Jacobs Sr.,” in Records of the Salem Witch-Hunt, ed. Bernard Rosenthal (Cambridge: Cambridge University Press, 2009), 251–52. Frances Hill, A Delusion of Satan: The Full Story of the Salem Witch Trials (New York: Da Capo Press, 1997), 203. “George Jacobs Sr. and the Salem Witch Trials.” History of Massachusetts Blog. Accessed May 13, 2026. History of Massachusetts. “George Jacobs Sr. Home Site.” Salem Witch Museum. Accessed May 13, 2026. Salem Witch Museum.   Interested in Salem The Podcast Merch!?  CLICK HERE! Interested in supporting the Podcast? Looking for more Salem content? CLICK HERE! www.salemthepodcast.com NEW INSTAGRAM - @salemthepod Email - hello@salemthepodcast.com   Book a tour with Sarah at Bewitched Historical Tours   www.bewitchedtours.com Book a tour with Jeffrey at Salem Uncovered Tours  www.salemuncoveredtours.com    Intro/Outro Music from Uppbeat: https://uppbeat.io/t/all-good-folks/unfamiliar-faces License code: NGSBY7LA1HTVAUJE

On a quiet October afternoon in 1961, 31-year-old Joan Risch vanished from her home in Lincoln, leaving behind a scene that investigators still can't fully explain. Blood was found smeared across the kitchen, the phone had been ripped from the wall, and strange sightings of a disoriented woman nearby only deepened the mystery. More than 60 years later, the disappearance of Joan Risch remains one of the most chilling unsolved cases in Massachusetts history.  Sources:  Kabra, Prathamesh, “What Really Happened to Joan Risch, the Massachusetts Housewife Who Vanished Without a Trace in 1961?”, Thar Tribune, August 15th, 2025, https://thartribune.com/what-really-happened-to-joan-risch-the-massachusetts-housewife-who-vanished-without-a-trace-in-1961/, Accessed May 18th, 2026   “Joan Carolyn Risch” The Charlie Project, Last updated December 5, 2018, https://charleyproject.org/case/joan-carolyn-risch, Accessed May 18th, 2026   City Towner, “The Disappearance of Joan Risch in Lincoln Massachusetts” City Towner, September 26, 2024, https://citytowner.com/lincoln-ma-joan-risch-disappearance/, Accessed May 18th, 2026  

After years of misdiagnoses, medication sensitivities, injuries, and setbacks, a massage therapist is diagnosed with Functional Neurological Disorder (FND), a condition that causes non-typical seizures and intermittent paralysis-like weakness. Despite being unable to work, she continues advocating for the FND community and wants to help educate massage therapists about the benefits of safe, informed touch for people living with the condition. In this episode of IHACW. . ., Ruth explores Sarah's journey, the realities of FND, and the role massage therapy may play in supporting those navigating complex neurological challenges.  Resources: Functional Neurologic Disorder | National Institute of Neurological Disorders and Stroke (no date a). Available at: https://www.ninds.nih.gov/health-information/disorders/functional-neurologic-disorder (Accessed: May 8, 2026). Functional Neurologic Disorder | National Institute of Neurological Disorders and Stroke (no date b). Available at: https://www.ninds.nih.gov/health-information/disorders/functional-neurologic-disorder (Accessed: April 28, 2026). Functional Neurological Disorder (Conversion Disorder) (no date). Available at: https://my.clevelandclinic.org/health/diseases/17975-conversion-disorder (Accessed: April 28, 2026). Functional Neurological Disorder, Reframed | Harvard Medicine Magazine (no date). Available at: https://magazine.hms.harvard.edu/articles/functional-neurological-disorder-reframed (Accessed: May 8, 2026). Ranford, J. et al. (2020) "Sensory Processing Difficulties in Functional Neurological Disorder: A Possible Predisposing Vulnerability?," Psychosomatics, 61(4), pp. 343–352. Available at: https://doi.org/10.1016/j.psym.2020.02.003. "What Is FND" (no date) FND Hope International. Available at: https://fndhope.org/fnd-guide/ (Accessed: April 28, 2026). What Is Functional Neurological Disorder (FND)? (no date) Cleveland Clinic. Available at: https://my.clevelandclinic.org/health/diseases/17975-conversion-disorder (Accessed: May 8, 2026).  Host Bio:              Ruth Werner is a former massage therapist, a writer, and an NCBTMB-approved continuing education provider. She wrote A Massage Therapist's Guide to Pathology, now in its seventh edition, which is used in massage schools worldwide. Werner is also a long-time Massage & Bodywork columnist, most notably of the Pathology Perspectives column. Werner is also ABMP's partner on Pocket Pathology, a web-based app and quick reference program that puts key information for nearly 200 common pathologies at your fingertips. Werner's books are available at www.booksofdiscovery.com. And more information about her is available at www.ruthwerner.com.    Sponsors: Anatomy Trains is a global leader in online anatomy education and also provides in-classroom certification programs for structural integration in the US, Canada, Australia, Europe, Japan, and China, as well as fresh-tissue cadaver dissection labs and weekend courses. The work of Anatomy Trains originated with founder Tom Myers, who mapped the human body into 13 myofascial meridians in his original book, currently in its fourth edition and translated into 12 languages. The principles of Anatomy Trains are used by osteopaths, physical therapists, bodyworkers, massage therapists, personal trainers, yoga, Pilates, Gyrotonics, and other body-minded manual therapists and movement professionals. Anatomy Trains inspires these practitioners to work with holistic anatomy in treating system-wide patterns to provide improved client outcomes in terms of structure and function.      Website: anatomytrains.com     Email: info@anatomytrains.com           Facebook: facebook.com/AnatomyTrains  Instagram: www.instagram.com/anatomytrainsofficial YouTube: https://www.youtube.com/channel/UC2g6TOEFrX4b-CigknssKHA    Precision Neuromuscular Therapy seminars (www.pnmt.org) have been teaching high-quality seminars for more than 20 years. Doug Nelson and the PNMT teaching staff help you to practice with the confidence and creativity that comes from deep understanding, rather than the adherence to one treatment approach or technique. Find our seminar schedule at pnmt.org/seminar-schedule with over 60 weekends of seminars across the country. Or meet us online in the PNMT Portal, our online gateway with access to over 500 videos, 37 NCBTMB CEs, our Discovery Series webinars, one-on-one mentoring, and much, much more! All for the low yearly cost of $167.50. Learn more at pnmt.thinkific.com/courses/pnmtportal!  Follow us on social media: @precisionnmt on Instagram or at Precision Neuromuscular Therapy Seminars on Facebook.   At Heights Wellness Retreat, we believe every person is an unstoppable force, whether navigating daily demands, pursuing goals, or striving to be their best. This drives everything we do. We go beyond traditional spa services by creating a purpose-driven environment where wellness professionals are empowered, valued, and positioned to grow. With steady clientele, support, and a wellness-forward culture, Heights Wellness Retreat is where therapists build meaningful, sustainable careers while shaping the future of the wellness industry.  www.massageheightscareers.careerplug.com/jobs  www.heightswellnessretreats.com  https://www.instagram.com/heightswellnessretreat/  https://www.facebook.com/heightswellnessretreat/   

Results from the first-in-human, phase 1 MYTHIC trial (NCT04855656) demonstrated that combining the WEE1 inhibitor zedoresertib with the PYKMT1 inhibitor lunresertib achieved an overall response rate (ORR) of 18.5% via RECIST criteria in patients with CCNE1, FBXW7, and PPP2R1A-altered cancers.1 In patients with resistant/refractory ovarian cancer, the ORR was 33.3% across all dose levels and 50% at the potential recommended phase 2 dose. These data were presented by Timothy A. Yap, MBBS, PhD, FRCP, at the 2026 American Association for Cancer Research (AACR) Annual Meeting. Following his presentation, Yap joined CancerNetwork® for a discussion where he highlighted some of the most interesting takeaways from the trial. According to Yap, the disease states evaluated in this trial represent areas of unmet need where no specific standard-of-care options can target these alterations.Notably, based on results from this trial, the FDA granted fast track designation to lunresertib in combination with zedoresertib in patients with genomic-defined platinum-resistant ovarian cancer.2Yap is a medical oncologist and physician-scientist, as well as the Random Horne, Jr. Endowed Professor for Cancer Research and vice president and head of Clinical Development in the Therapeutics Discovery Division at UT MD Anderson Cancer Center.References1.        Yap TA, Aggarwal R, Fontana E, et al. First data disclosure of the Phase I trial of the first in class combination of WEE1 inhibitor zedoresertib with PKMYT1 inhibitor lunresertib in patients with advanced solid tumors harboring CCNE1, FBXW7, or PPP2R1A genomic alterations. Presented at the 2026 AACR Annual Meeting; April 17-22, 2026; San Diego, CA. Abstract CT022.2.        Following oral presentation of phase I Data at AACR 2026, Debiopharm announces FDA fast track designation for lunresertib in combination with zedoresertib for genomic-defined platinum-resistant ovarian cancer. News release. Debiopharm. April 20, 2026. Accessed May 4, 2026. https://shorturl.at/n1bWn

On August 19, 1692, Salem witnessed the executions of five innocent victims found guilty of Sundry Acts of Witchcraft. We've done deep dives into four of those five victims' stories. And today, we tackle the one remaining: George Jacobs Sr. He was the oldest victim of the Salem Witch Trials and probably had the sharpest tongue. In comparison to other accused, little is known about Jacobs. He seemed to be a law-abiding man who avoided gossip and controversy. Join Sarah and Jeffrey, your favorite Salem tour guides, as they learn what about this man made him such a target. “Case Files Referencing George Jacobs Sr.” Salem Witch Trials Documentary Archive and Transcription Project. Accessed May 13, 2026. (salem.lib.virginia.edu) Charles Wentworth Upham, Salem Witchcraft, vol. 2 (Boston: Wiggin and Lunt, 1867), 427. Emerson W. Baker, A Storm of Witchcraft: The Salem Trials and the American Experience (New York: Oxford University Press, 2015), 148. “Examination of George Jacobs Sr.,” in Records of the Salem Witch-Hunt, ed. Bernard Rosenthal (Cambridge: Cambridge University Press, 2009), 251–52. Frances Hill, A Delusion of Satan: The Full Story of the Salem Witch Trials (New York: Da Capo Press, 1997), 203. “George Jacobs Sr. and the Salem Witch Trials.” History of Massachusetts Blog. Accessed May 13, 2026. History of Massachusetts. “George Jacobs Sr. Home Site.” Salem Witch Museum. Accessed May 13, 2026. Salem Witch Museum.   Interested in Salem The Podcast Merch!?  CLICK HERE! Interested in supporting the Podcast? Looking for more Salem content? CLICK HERE! www.salemthepodcast.com NEW INSTAGRAM - @salemthepod Email - hello@salemthepodcast.com   Book a tour with Jeffrey at Salem Uncovered Tours  www.salemuncoveredtours.com  Book a tour with Sarah at Bewitched Historical Tours   www.bewitchedtours.com   Intro/Outro Music from Uppbeat: https://uppbeat.io/t/all-good-folks/unfamiliar-faces License code: NGSBY7LA1HTVAUJE

On August 19, 1692, Salem witnessed the executions of five innocent victims found guilty of Sundry Acts of Witchcraft. We've done deep dives into four of those five victims' stories. And today, we tackle the one remaining: George Jacobs Sr. He was the oldest victim of the Salem Witch Trials and probably had the sharpest tongue. In comparison to other accused, little is known about Jacobs. He seemed to be a law-abiding man who avoided gossip and controversy. Join Sarah and Jeffrey, your favorite Salem tour guides, as they learn what about this man made him such a target. “Case Files Referencing George Jacobs Sr.” Salem Witch Trials Documentary Archive and Transcription Project. Accessed May 13, 2026. (salem.lib.virginia.edu) Charles Wentworth Upham, Salem Witchcraft, vol. 2 (Boston: Wiggin and Lunt, 1867), 427. Emerson W. Baker, A Storm of Witchcraft: The Salem Trials and the American Experience (New York: Oxford University Press, 2015), 148. “Examination of George Jacobs Sr.,” in Records of the Salem Witch-Hunt, ed. Bernard Rosenthal (Cambridge: Cambridge University Press, 2009), 251–52. Frances Hill, A Delusion of Satan: The Full Story of the Salem Witch Trials (New York: Da Capo Press, 1997), 203. “George Jacobs Sr. and the Salem Witch Trials.” History of Massachusetts Blog. Accessed May 13, 2026. History of Massachusetts. “George Jacobs Sr. Home Site.” Salem Witch Museum. Accessed May 13, 2026. Salem Witch Museum.   Interested in Salem The Podcast Merch!?  CLICK HERE! Interested in supporting the Podcast? Looking for more Salem content? CLICK HERE! www.salemthepodcast.com NEW INSTAGRAM - @salemthepod Email - hello@salemthepodcast.com   Book a tour with Jeffrey at Salem Uncovered Tours  www.salemuncoveredtours.com  Book a tour with Sarah at Bewitched Historical Tours   www.bewitchedtours.com   Intro/Outro Music from Uppbeat: https://uppbeat.io/t/all-good-folks/unfamiliar-faces License code: NGSBY7LA1HTVAUJE

Oh, What's in a Name? Irving F. Stein and Michael L. Leventhal first described the syndrome, originally known as Stein-Leventhal syndrome, in 1935, in the AJOG. They published a case series of seven women displaying a triad of symptoms, including hirsutism, amenorrhea (absent menstruation), and bilaterally enlarged polycystic ovaries. We now know that PCOS affects 1 in 8 women globally (170 million women of reproductive age worldwide), and that there are 4 main manifestations of the condition- reflecting its diverse phenotype. Now, as of 05/12/25, a collaboration across 56 leading academic, clinical, and patient organizations, as well as iterative global surveys that garnered responses from over 14,300 people with PCOS and multidisciplinary health professionals have endorsed a NEW term (Lancet) for this: polyendocrine metabolic ovarian syndrome. This is actually STAGE 7 of an 8 stage process Yep, 1-6 are already done). But hold on…this is not taking over tomorrow! There is a THREE-YEAR implementation strategy that has already gotten started and culminating in 2028. Listen in for details.1. Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. Published online May 12, 2026. Accessed May 12, 2026. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext2. International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome; 20233. https://www.contemporaryobgyn.net/view/global-consensus-renames-pcos-to-polyendocrine-metabolic-ovarian-syndrome-pmos-?utm_campaign=42986360-COG%20-%20Breaking%20News&utm_medium=email&_hsenc=p2ANqtz--5Of8-OwjOeKLtknr8YdFbh9G8_c7iQqliHnMz2pYOpi2x4Pp8dRH6bSHjrQIqnth_fLPywQM2ByNp7via22VJ8yyLbg&_hsmi=418414457&utm_content=418414457&utm_source=hs_email4. Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. Monash University. News release. May 12, 2026. Accessed May 12, 2026. https://www.eurekalert.org/news-releases/1127647

In this special Complex Care Journal Club podcast episode, co-hosts Drs. Emily Goodwin, Kristie Malik, and Kathleen Huth interview presenters of posters and oral abstracts relevant to the care of children with medical complexity at the Pediatric Academic Societies (PAS) 2026 annual meeting, as well as at a pre-PAS event focused on home- and community-based care and training in complex care. Speakers describe their key findings, messages for care teams including patients and families, and opportunities to translate their findings into practice.‌ SPEAKERS Flor Arellano, MPH Clinical Research Coordinator, University of California, Los Angeles Jennifer Arnold, MD, MSc Medical Director, Skeletal Health, Boston Children's Hospital Ryan Brewster, MD Neonatal- Perinatal Medicine Fellow, Stanford University School of Medicine Meg Comeau, MHA Senior Project Director, Center for Innovation in Social Work & Health, Boston University School of Social Work John Greenwood, PT Executive Director for Physical Therapy, Occupational Therapy and Rehabilitation Services, Boston Children's Hospital Elaine Lin, MD Complex Care Pediatrician, Boston Children's Hospital Michelle Macy, MD, MS Professor of Pediatrics, Northwestern University Feinberg School of Medicine Scientific Director, Community, Population Health, and Outcomes, Research and Evaluation Center, Ann & Robert H. Lurie Children's Hospital of Chicago Ashley Nmoh, BA Medical Student, Duke University School of Medicine Jennifer Peralta, MD, MSHPN Assistant Clinical Professor, University of California, Los Angeles Nora Renthal, MD, PhD Assistant Professor of Pediatric Endocrinology, Boston Children's Hospital Erin Ward, MEd Patient Engagement Consultant, Complex Care Service, Boston Children's Hospital HOSTS Emily J. Goodwin, MD Clinical Associate Professor of Pediatrics, University of Missouri Kansas City School of Medicine Pediatrician, General Academic Pediatrics Beacon Program, Children's Mercy Kansas City Kristina Malik, MD Assistant Professor of Pediatrics, University of Colorado School of Medicine Medical Director, KidStreet Pediatrician, Special Care Clinic, Children's Hospital Colorado Kathleen Huth, MD, MMSc Pediatrician, Complex Care Service, Division of General Pediatrics, Boston Children's Hospital Assistant Professor of Pediatrics, Harvard Medical School DATE Initial publication date: May 11, 2026. ARTICLES REFERENCED - Brewster RC, Kats DJ, Elborki M, Chilukuri N, Ray M, Shaar N, Hron J, Khan A. Clinical Outcomes of Postedited Artificial Intelligence Translation for Discharge Instructions. Hosp Pediatr. 2026 Apr 10:e2025008986. doi: 10.1542/hpeds.2025-008986. Epub ahead of print. PMID: 41956490. - FamilyCIRCLE. University of Wisconsin–Madison, Department of Pediatrics. Accessed May 4, 2026. https://familycircle.pediatrics.wisc.edu/ - Pediatric Academic Societies. Online program guide. Accessed May 4, 2026. https://2026.pas-meeting.org/ - Pediatric Academic Societies. Who we are. Accessed May 4, 2026. https://www.pas-meeting.org/about/ - Pediatric Academic Societies. Academic Pediatric Association (APA) awards. Accessed May 4, 2026. https://www.pas-meeting.org/2026-awards-apa/‌ TRANSCRIPT https://cdn.bfldr.com/D6LGWP8S/as/k7qqm93qqpqgb5k3jw4f3w2t/PAS_2026_conference_transcript_5-8-26‌ Clinicians across healthcare professions, advocates, researchers, and patients/families are all encouraged to engage and provide feedback! You can recommend an article for discussion using this form: https://forms.gle/Bdxb86Sw5qq1uFhW6. CITATION Goodwin EJ, Malik K, Arellano F, Arnold J, Brewster R, Comeau M, Greenwood J, Lin E, Macy M, Nmoh A, Peralta J, Renthal N, Ward E, Huth K. Practice-Changing Research in Complex Care at the Pediatric Academic Societies 2026 Annual Meeting. 05/2026. OPENPediatrics. Online Podcast. https://soundcloud.com/openpediatrics/practice-changing-research-in-complex-care-pediatric-academic-societies-2026.

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss a slew of advances in diabetes technology and treatments, starting with the US Food and Drug Administration (FDA)'s recent approval of the Tandem automated insulin delivery system for use during pregnancy in individuals with type 1 diabetes. The conversation centers on findings from the CIRCUIT trial, which demonstrated significant improvements in time in range among pregnant patients, a population historically challenging to manage because of stringent glycemic targets. Isaacs and Bellini review practical considerations from the study, including the use of continuous sleep mode to target tighter glucose ranges and proactive optimization of basal rates, correction factors, and carbohydrate ratios to improve outcomes. They emphasize that FDA approval now allows clinicians and manufacturers to openly discuss evidence-based best practices for pregnancy management using automated insulin delivery systems.The hosts also highlight the importance of clinician comfort with aggressive insulin automation during pregnancy, noting that increased basal modulation, suspensions, and automated adjustments should be expected as physiologic insulin needs fluctuate throughout gestation. Bellini stresses the importance of reducing patient burden while maintaining intensive glycemic management, tying this theme into Tandem's newly announced compatibility with the Dexcom G7 15-day sensor. Both hosts note strong patient enthusiasm for extending sensor wear time, framing reduced device maintenance as an important quality-of-life improvement even when the practical change appears modest.The discussion then shifts to immunotherapy in type 1 diabetes, focusing on the expanded approval of teplizumab to include children as young as 1 year old for delaying progression from stage 2 to stage 3 disease. Isaacs and Bellini underscore how broader eligibility may strengthen adoption of autoantibody screening among relatives of patients with type 1 diabetes. They review evidence showing that screening substantially lowers rates of diabetic ketoacidosis at diagnosis and discuss the broader clinical significance of delaying symptomatic disease onset, even when delays are shorter than the median duration reported in trials. The hosts note that many families value the possibility of a more gradual transition into insulin dependence, often requiring only minimal insulin therapy initially rather than presenting with severe metabolic decompensation.The conversation also addresses ongoing regulatory developments surrounding teplizumab for newly diagnosed stage 3 type 1 diabetes. Although the anticipated expedited review pathway has been withdrawn, the hosts remain optimistic about eventual approval, citing encouraging data and the growing role of precision medicine approaches in identifying patients most likely to benefit from immune intervention.To conclude the episode, Isaacs and Bellini examine a post hoc analysis from the SURMOUNT-5 trial comparing tirzepatide and semaglutide in adults with obesity and prediabetes. They discuss findings showing high rates of reversion to normoglycemia in both treatment groups, with tirzepatide demonstrating greater efficacy overall. The hosts frame these data within the broader movement to reconceptualize prediabetes as an earlier stage of type 2 diabetes and cardiovascular disease risk rather than a benign precursor state. They emphasize the potential value of earlier therapeutic intervention to prevent progression and reduce long-term cardiometabolic complications while also acknowledging the importance of maintaining multiple treatment options because of variability in medication tolerability and patient response.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others.References1: Tandem Diabetes Care. Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes. April 27, 2026. Accessed May 8, 2026. https://investor.tandemdiabetes.com/news-releases/news-release-details/tandem-diabetes-cares-control-iq-automated-insulin-delivery2: Sanofi. Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children. April 22, 2026. Accessed May 8, 2026. https://www.sanofi.com/en/media-room/press-releases/2026/2026-04-22-05-05-00-32786503: Galindo RJ, Aronne LJ, Horn DB, et al. Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5. J Endocrinol Invest. Published online April 20, 2026. doi:10.1007/s40618-026-02895-3

In the news cycle, an elderly woman attempting to poison her husband would have garnered a pretty small amount of attention from the press, then faded away when a larger story came along. But it didn't take long for the press to learn that the poisoning of Melissa Ann Shepard's new husband wasn't  the first time she had been suspected or convicted of attempted murder. In fact, Melissa Ann Shepard had a criminal history in two countries that went back decades, including many crimes that were very similar to the one she had just perpetrated only with a much worse outcome. Recommendations Follow @itsmartymiller on TikTok   References As It Happens. 2016. Victim questions release of notorious Internet Black Widow. March 16. Accessed May 14, 2024. https://www.cbc.ca/radio/asithappens/as-it-happens-tuesday-edition-1.3492260/victim-questions-release-of-notorious-internet-black-widow-she-ll-never-change-1.3492579. Associated Press. 2005. "'Black Widow' pleads guilty." Kingston Whig-Standard, March 15: 2005. Canadian Press. 2013. "'Black Widow' pleads guilty to drugging husband's coffee days after wedding." Globe and Mail, June 11. —. 2016. "Internet black widow off the hook." Hamilton Spectator, December 23: 10. —. 2013. "'Black Widow' gets 3 1/2 years for drugging husband." Toronto Star, June 12. —. 2013. "Alleged victim of 'Black Widow' holds no ill will as trial set to start." Windsor Star, June 7: 35. 2012. The Fifth Estate: The Widow's Web. Television. Directed by CBC News. Performed by CBC News. Elash, Anita. 2012. Police were asked to warn husband of 'Internet Black Widow'. October 5. Accessed May 15, 2024. https://www.cbc.ca/news/canada/police-were-asked-to-warn-husband-of-internet-black-widow-1.1163836. L'Heureux, Catie. 2016. "The real-life Gone Girl is 80, and terrifying." The Cut, April 13. McMahon, Tamsin. 2005. "Robert Friedrich was alive and well, then he met this woman." Kingston Whig-Standard, April 9: 1. O'Connor, Joe. 2012. "Romancing the 'Black Widow' ." National Post, October 3: 1. Sherren, Reg. 2013. "Internet Black Widow 'will do it again,' says former husband." CBC News, September 16. Starnes, Richard. 2005. "'Black widow' arrested in Florida." Ottawa Citizen, January 13: 7. Cowritten by Alaina Urquhart, Ash Kelley & Dave White (Since 10/2022)Produced & Edited by Mikie Sirois (Since 2023)Research by Dave White (Since 10/2022), Alaina Urquhart & Ash KelleyListener Correspondence & Collaboration by Debra LallyListener Tale Video Edited by Aidan McElman (Since 6/2025) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We know we want kids to have choice. As much choice as possible in creating the education that is meaningful and helpful for them. That choice can come through choice over content, medium, expression of ideas, types of discussion, seating in the classroom, what to work on when, when to take a break...there are so many possibilities! If you make it a professional challenge to start seeing the possibilities for choice, you'll find them everywhere! As I've been working on choice as a theme for The Lighthouse this month, I knew that I wanted to create a final choice board project adaptable for any text that would provide a range of options for students. But I also knew I wanted to avoid the pitfalls of some of the choice projects I designed for my own classroom, when I ended up having to create seven different rubrics and rewire myself for a huge range of requirements on my different project options as I graded them. While I was glad to give my students those choices, it was frustrating how long it took to complete my comments. So I took some of my favorite types of projects, what I've learned about creating linked hyperdocs, and my strong desire for an easy grading situation and mashed it all up into an adaptable final project with nine choices, including one that allows students to create their own way to make meaning from what they've studied (so really, a million choices). I'm going to walk you through the process today, so you can do the same next time you'd like to create a project full of options, gifting your students agency as they synthesize what they've learned and create something new. Let's dive in. Go Further:  Explore alllll the Episodes of The Spark Creativity Teacher Podcast. Snag three free weeks of community-building attendance question slides Join our community, Creative High School English, on Facebook. Come hang out on Instagram. Enjoying the podcast? Please consider sharing it with a friend, snagging a screenshot to share on the 'gram, or tapping those ⭐⭐⭐⭐⭐ to help others discover the show. Thank you! Sources Considered: Beghetto, Ronald. "Does Assessment Kill Student Creativity?" The Educational Forum, 2005. Beghetto, Ronald. Killing Ideas Softly: The Promise & Peril of Creativity in the Classroom. Information Age Publishing, 2017. Accessed Online through the Ebesco Database. Chavez, Felicia. The Anti-Racist Writer's Workshop. Haymarket Books, 2021. Gabriel, Elise. "Six Ways to Help Kids Grow their Creativity." Greater Good Magazine Online: https://greatergood.berkeley.edu/article/item/six_ways_to_help_kids_grow_their_creativity. Accessed 28 October 2025. Gonzalez, Jennifer. "Meet the Single Point Rubric." Cult of Pedagogy Online: https://www.cultofpedagogy.com/single-point-rubric/. Accessed May 2025. Pringle, Zorana Ivcevic. The Creativity Choice. Public Affairs: 2025. Wiggins, Grant. "Creative." https://grantwiggins.wpcomstaging.com/wp-content/uploads/2012/02/creative.pdf. Accessed 28 October 2025.  

Overview: In this episode, Dr Joel Gallant gives a history of antiretroviral therapy and HIV drug resistance, drawing on his personal and professional experience beginning in the early 1980s. The views expressed are those of the panelist and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in August 2023 and the content reflects the information available at that time. Guest: Joel Gallant, MD, MPH    For more information, please visit: https://www.pri-med.com/clinical-resources/curriculum/hiv-in-focus    References AIDSVu.org. New HIV diagnoses. 2023. Available from: https://aidsvu.org/local-data/united-states/south/ (Accessed May 19, 2025) AIDSVu.org was developed by the Rollins School of Public Health at Emory University in partnership with Gilead Sciences, Inc. Alonso A, de Irala J. Strategies in HIV prevention: the A-B-C approach. Lancet 2004;364:1033. Available from: https://doi.org/10.1016/s0140-6736(04)17050-5 Bacheler L, Jeffrey S, Hanna G et al. Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol 2001;75:4999–5008. Available from: https://doi.org/10.1128/jvi.75.11.4999-5008.2001 Barré-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220:868–71. Available from: https://doi.org/10.1126/science.6189183 Bayer R, Edington C. HIV testing, human rights, and global AIDS policy: exceptionalism and its discontents. J Health Polit Policy Law 2009;34:301–23. Available from: https://doi.org/10.1215/03616878-2009-002 Centers for Disease Control and Prevention. Pneumocystis pneumonia – Los Angeles. MMWR Morb Mortal Wkly Rep 1981;30:250-2. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm Centers for Disease Control and Prevention. Preventing HIV. 2024. Available from: https://www.cdc.gov/hiv/prevention/index.html (Accessed May 22, 2025) Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505. Available from: https://doi.org/10.1056/NEJMoa1105243 Cuevas JM, Geller R, Garijo R et al. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol 2015;13:e1002251. Available from: https://doi.org/10.1371/journal.pbio.1002251 Department of Health and Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2024. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/optimizing-antiretroviral-therapy (Accessed May 19, 2025) Dragovic G. Acute pancreatitis in HIV/AIDS patients: an issue of concern. Asian Pac J Trop Biomed 2013;3:422–425. Available from: https://doi.org/10.1016%2FS2221-1691(13)60091-X Eron JJ, Benoit SL, Jemsek J et al. Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party. N Engl J Med 1995;333:1662–9. Available from: https://doi.org/10.1056/nejm199512213332502 Gandhi RT, Tashima KT, Smeaton LM et al. Long-term outcomes in a large randomized trial of HIV-1 salvage therapy: 96-week results of AIDS clinical trials group A5241 (OPTIONS). J Infect Dis 2020;221:1407–15. Available from: https://doi.org/10.1093/infdis/jiz281 Getting to Zero San Francisco. HIV epidemiology annual report 2017. 2022. Available from: https://gettingtozerosf.org/getting-to-zero-resources/hiv-report-2017/ (Accessed May 22, 2025) Global Fund. About the Global Fund. 2024. Available from: https://www.theglobalfund.org/en/about-the-global-fund/ (Accessed May 19, 2025) Gulick RM, Lalezari J, Goodrich J et al. Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med 2008;359:1429–41. Available from: https://doi.org/10.1056/NEJMoa0803152 Gulick RM, Mellors JW, Havlir D et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734–9. Available from: https://doi.org/10.1056/nejm199709113371102 Haubrich R, Berger D, Chiliade P et al. Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients. AIDS 2007;21:F11–8. Available from: https://doi.org/10.1097/QAD.0b013e3280b07b47 HIV Prevention Trials Network. HPTN 052. 2023. Available from: https://www.hptn.org/research/studies/hptn052 (Accessed May 19, 2025) HIV.gov. HIV and AIDS timeline. 2024. Available from: https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline/ (Accessed May 19, 2025) HIVinfo.NIH.gov. FDA approval of HIV medicines. 2024. Available from: https://hivinfo.nih.gov/understanding-hiv/infographics/fda-approval-hiv-medicines (Accessed May 19, 2025) i-base. Cross-resistance by drug class. 2025. Available from: https://i-base.info/guides/changing/cross-resistance (Accessed May 19, 2025) Iyidogan P, Anderson KS. Current perspectives on HIV-1 antiretroviral drug resistance. Viruses 2014;6:4095–139. Available from: https://doi.org/10.3390/v6104095 Lalezari JP, Henry K, O'Hearn M et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med 2003;348:2175–85. Available from: https://doi.org/10.1056/NEJMoa035026 Landovitz RJ, Donnell D, Clement ME et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med 2021;385:595–608. Available from: https://doi.org/10.1056/NEJMoa2101016 Larder BA, Darby G, Richman DD. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989;243:1731–4. Available from: https://doi.org/10.1126/science.2467383 Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr 2007;44:179–87. Available from: https://doi.org/10.1097/01.qai.0000247229.68246.c5 Lucas C. The San Francisco model and the nurses of Ward 5B. Lancet HIV 2019;6:E819. Available from: https://doi.org/10.1016/S2352-3018(19)30267-X Madruga JV, Cahn P, Grinsztejn B et al. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial. Lancet 2007;370:29–38. Available from: https://doi.org/10.1016/s0140-6736(07)61047-2 Marcelin AG. Resistance to nucleoside reverse transcriptase inhibitors. In: Geretti AM, editor. Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 1. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2241/ Margolis AM, Heverling H, Pham PA et al. A review of the toxicity of HIV medications. J Med Toxicol 2014;10:26–39. Available from: https://doi.org/10.1007/s13181-013-0325-8 Moore RD, Creagh-Kirk T, Keruly J et al. Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group. Arch Intern Med 1991;151:981–6. Available from: https://doi.org/10.1001/archinte.1991.00400050123023 National Institute of Allergy and Infectious Diseases. HIV Undetectable = Untransmittable (U = U), or treatment as prevention. 2019. Available from: https://www.niaid.nih.gov/diseases-conditions/treatment-prevention (Accessed May 19, 2025) Nelson MR, Katlama C, Montaner JS et al. The safety of […] for the treatment of HIV infection in adults: the first 4 years. AIDS 2007;21:1273–81. Available from: https://doi.org/10.1097/QAD.0b013e3280b07b33 New York State Department of Health. Pre-exposure prophylaxis (PrEP) to prevent HIV infection: question and answers. 2012. Available from: https://www.health.ny.gov/publications/0265/ (Accessed May 22, 2025) Overton ET, Richmond G, Rizzardini G et al. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with human immunodeficiency virus 1 type 1 infection: 152-week results from ATLAS-2M, a randomized, open-label, phase 3b, noninferiority study. Clin Infect Dis 2023;76:1646–54. Available from: https://doi.org/10.1093/cid/ciad020 Pollak EB, Parmar M. Indinavir. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554396/ (Accessed May 19, 2025) Richman DD, Fischl MA, Grieco MH et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987;317:192–7. Available from: https://doi.org/10.1056/nejm198707233170402 Schmit JC, Ruiz L, Clotet B et al. Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538). AIDS 1996;10:995–9. Available from: https://doi.org/10.1097/00002030-199610090-00010 Siliciano JD, Kajdas J, Finzi D et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 2003;9:727–8. Available from: https://doi.org/10.1038/nm880 Steigbigel RT, Cooper DA, Kumar PN et al. Raltegravir with optimized background therapy for resistant HIV-1 infection. N Engl J Med 2008;359:339–54. Available from: https://doi.org/10.1056/NEJMoa0708975 TIME. Man of the year. 1996. Available from: https://time.com/vault/issue/1996-12-30/page/1/ (Accessed May 19, 2025) U.S. President's Emergency Plan for AIDS Relief (PEPFAR). About us. 2025. Available from: https://www.state.gov/about-us-pepfar/ (Accessed May 19, 2025)

Overview: In this episode, Toyin Nwafor, MD, and Christian B Ramers, MD, draw on their experience in primary care, HIV and HIV prevention to highlight missed opportunities for HIV prevention and discuss strategies to help address gaps in the HIV care continuum. The views expressed are those of the panelist(s) and not necessarily Gilead Sciences, Inc. The information provided in this podcast is not intended to be and should not be understood to provide medical advice. Listeners should note that our discussions in this episode are relevant to the USA only and may not be appropriate for other regions. This episode was recorded in August 2025 and the content reflects the information available at that time. Guest: Toyin Nwafor, MD; Christian B Ramers, MD, MPH, FIDSA, AAHIVS   For more information, please visit: https://www.pri-med.com/clinical-resources/curriculum/hiv-in-focus  References AIDSVu.org. Prevalence in the United States. 2022. Available from: https://map.aidsvu.org/ (Accessed June 25, 2025). AIDSVu.org was developed by the Rollins School of Public Health at Emory University in partnership with Gilead Sciences, Inc. Baeten J et al. Curr HIV/AIDS Rep 2013;10:142–51. CDC. Clinical testing guidance for HIV. 2025. Available from: https://www.cdc.gov/hivnexus/hcp/diagnosis-testing/index.html (Accessed June 25, 2025). CDC. Discussing sexual health with your patients. 2025. Available from: https://www.cdc.gov/hivnexus/hcp/sexual-history/index.html (Accessed June 25, 2025). CDC.gov. HIV diagnoses, deaths, and prevalence. 2025. Available from: https://www.cdc.gov/hiv-data/nhss/hiv-diagnoses-deaths-prevalence.html (Accessed June 25, 2025). CDC. National HIV prevention and care objectives: 2025 update. 2025. Available from: https://www.cdc.gov/hiv-data/nhss/national-hiv-prevention-and-care-objectives-2025.html (Accessed June 25, 2025). CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States – 2021 update: a clinical practice guideline. 2021. Available from: https://stacks.cdc.gov/view/cdc/112360 (Accessed June 25, 2025). Doblecki-Lewis S et al. J Int Assoc Provid AIDS Care 2019;18:2325958219848848. DHHS. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2024. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf (Accessed June 25, 2025). HIV.gov. Key EHE strategies. 2024. Available from: https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/key-strategies (Accessed June 2, 2025). HIV.gov. HIV treatment as prevention. 2023. Available from: https://www.hiv.gov/tasp (Accessed June 25, 2025). HIV.gov. US statistics. 2025. Available from: https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics (Accessed May 21, 2025). HIV.gov. Viral suppression and undetectable viral load. 2025. Available from: https://www.hiv.gov/hiv-basics/staying-in-hiv-care/hiv-treatment/viral-suppression (Accessed July 18, 2025). HIV.gov. Who is at risk for HIV. 2025. Available from: https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/who-is-at-risk-for-hiv (Accessed June 25, 2025). Johns Hopkins Bloomberg School of Public Health. What to know about PrEP. 2025. Available from: https://publichealth.jhu.edu/2025/who-needs-prep-for-hiv-prevention (Accessed June 25, 2025). Kamis KF et al. Open Forum Infect Dis 2019;6:ofz310. KFF. HIV testing in the United States. 2024. Available from: https://www.kff.org/hiv-aids/hiv-testing-in-the-united-states/ting in the United States | KFF (Accessed August 26, 2025). NIH. HIV and sexually transmitted infections (STIs). 2021. Available from: https://hivinfo.nih.gov/understanding-hiv/fact-sheets/hiv-and-sexually-transmitted-infections-stis (Accessed June 25, 2025). Ramchandani MS et al. Curr HIV/AIDS Rep 2019;16:244–56. Saag MS et al. JAMA 2018;320:379–96. Sweeney P et al. J Acquir Immune Defic Syndr 2019;82(Suppl 1):S1–5. The White House. National HIV/AIDS strategy for the United States 2022–2025. 2021. Available from: https://files.hiv.gov/s3fs-public/NHAS-2022-2025.pdf (Accessed June 25, 2025). UNAIDS.org. Recommended 2030 targets for HIV. 2025. Available from: https://www.unaids.org/en/recommended-2030-targets-for-hiv (Accessed August 26, 2025). United States Census Bureau. National population by characteristics: 2020-2024. 2024. Available from: https://www.census.gov/data/tables/time-series/demo/popest/2020s-national-detail.html (Accessed June 25, 2025). United States Census Bureau. United States Population Growth by Region. 2025. Available from: https://www.census.gov/popclock/ (Accessed June 25, 2025). Yumori C et al. Sex Transm Dis 2021;48:32–6.

Throughout the 1970s, Southern California residents were held in the grip of terror as multiple serial killers stalked the streets, preying on victims from every walk of life, including the area's gay community. From 1971 to 1983, Randy Kraft kidnapped, tortured, and murdered at least sixteen men and boys, but the real number of victims is believed to be considerably higher. When he was arrested in 1983, investigators searched Kraft's home and found a list with cryptic references to what they believed were sixty-one victims in total. The discovery of that list led the press to dub Kraft “The Scorecard Killer.”Following his arrest in 1983, Randy Kraft was tried and convicted of sixteen counts of first-degree murder and sentenced to death. Although the arrest and trial put an end to Kraft's murder spree, several critical questions remain unanswered, including the most important aspect of the case detectives were never able to solve: who was Randy Kraft's accomplice?Thank you to the Incredible Dave White of Bring Me the Axe Podcast for research and Writing support!ReferencesArnold, Roxane, and Jerry Hicks. 1983. "Kraft suspected in deaths of 14 men in 3 states, Gates says." Los Angeles Times, May 20: 73.Associated Press. 1983. "Five murders charged to computer analyst." Sacramento Bee, May 25: 2.—. 1978. "Police seek link in deaths of 18." San Bernardino County Sun, November 24: 3.—. 1983. "Freeway killing pattern repeats." The Tribune (San Luis Obispo, CA), February 19: 2.Bajko, Matthew. 2016. Gay serial killer breaks silence. November 2. Accessed May 15, 2025. https://www.ebar.com/story/246748.Grant, Gordon. 1983. "How a routine stop led to a big arrest." Los Angeles Times, May 20: 73.Hicks, Jerry. 1988. "Alleged 'death list' made public as Kraft trial opens." Los Angeles Times, September 27: 69.—. 1989. "Kraft condemned to death by jury for serial killings." Los Angeles Times, August 12: 1.—. 1988. "Kraft defense says marine found in car was not dead." Los Angeles Times, September 28: 76.—. 1989. "Kraft guilty of 16 sex slayings, jury decides." Los Angeles Times, May 13: 1.—. 1989. "Orange County jury gets Kraft serial murder case." Los Angeles Times, April 28: 76.—. 1988. "Two other states were closing in on Kraft." Los Angeles Times, January 4: 3.—. 1989. "Witness says Kraft drugged and sexually assaulted him in 1970." Los Angeles Times, June 6: 3.Hughes, Beth. 1982. "L.A. area's missing youths-a trail of mystery and murder." San Francisco Examiner, August 23: B5.Jarlson, Gary. 1983. "Suspect in 4 slayings also investigated in 6 Oregon murders." Los Angeles Times, May 19: 80.Kennedy, J. Michael. 1978. "Four deaths turn into four mysteries." Los Angeles Times, September 2: 17.Los Angeles Times. 1973. "Head of a man found in a bag at paper plant." Los Angeles Times, April 27: 23.—. 1988. "Randy Kraft's scorecard?" Los Angeles Times, October 2: 117.McDougal, Dennis. 1991. Angel of Darkness: The True Story of Randy Kraft and the Most Heinous Murder Spree. New York, NY: Warner Books. Stay in the know - wondery.fm/morbid-wondery.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Throughout the 1970s, Southern California residents were held in the grip of terror as multiple serial killers stalked the streets, preying on victims from every walk of life, including the area's gay community. From 1971 to 1983, Randy Kraft kidnapped, tortured, and murdered at least sixteen men and boys, but the real number of victims is believed to be considerably higher. When he was arrested in 1983, investigators searched Kraft's home and found a list with cryptic references to what they believed were sixty-one victims in total. The discovery of that list led the press to dub Kraft “The Scorecard Killer.”Following his arrest in 1983, Randy Kraft was tried and convicted of sixteen counts of first-degree murder and sentenced to death. Although the arrest and trial put an end to Kraft's murder spree, several critical questions remain unanswered, including the most important aspect of the case detectives were never able to solve: who was Randy Kraft's accomplice?Thank you to the Incredible Dave White of Bring Me the Axe Podcast for research and Writing support!ReferencesArnold, Roxane, and Jerry Hicks. 1983. "Kraft suspected in deaths of 14 men in 3 states, Gates says." Los Angeles Times, May 20: 73.Associated Press. 1983. "Five murders charged to computer analyst." Sacramento Bee, May 25: 2.—. 1978. "Police seek link in deaths of 18." San Bernardino County Sun, November 24: 3.—. 1983. "Freeway killing pattern repeats." The Tribune (San Luis Obispo, CA), February 19: 2.Bajko, Matthew. 2016. Gay serial killer breaks silence. November 2. Accessed May 15, 2025. https://www.ebar.com/story/246748.Grant, Gordon. 1983. "How a routine stop led to a big arrest." Los Angeles Times, May 20: 73.Hicks, Jerry. 1988. "Alleged 'death list' made public as Kraft trial opens." Los Angeles Times, September 27: 69.—. 1989. "Kraft condemned to death by jury for serial killings." Los Angeles Times, August 12: 1.—. 1988. "Kraft defense says marine found in car was not dead." Los Angeles Times, September 28: 76.—. 1989. "Kraft guilty of 16 sex slayings, jury decides." Los Angeles Times, May 13: 1.—. 1989. "Orange County jury gets Kraft serial murder case." Los Angeles Times, April 28: 76.—. 1988. "Two other states were closing in on Kraft." Los Angeles Times, January 4: 3.—. 1989. "Witness says Kraft drugged and sexually assaulted him in 1970." Los Angeles Times, June 6: 3.Hughes, Beth. 1982. "L.A. area's missing youths-a trail of mystery and murder." San Francisco Examiner, August 23: B5.Jarlson, Gary. 1983. "Suspect in 4 slayings also investigated in 6 Oregon murders." Los Angeles Times, May 19: 80.Kennedy, J. Michael. 1978. "Four deaths turn into four mysteries." Los Angeles Times, September 2: 17.Los Angeles Times. 1973. "Head of a man found in a bag at paper plant." Los Angeles Times, April 27: 23.—. 1988. "Randy Kraft's scorecard?" Los Angeles Times, October 2: 117.McDougal, Dennis. 1991. Angel of Darkness: The True Story of Randy Kraft and the Most Heinous Murder Spree. New York, NY: Warner Books. Stay in the know - wondery.fm/morbid-wondery.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Throughout the 1970s, Southern California residents were held in the grip of terror as multiple serial killers stalked the streets, preying on victims from every walk of life, including the area's gay community. From 1971 to 1983, Randy Kraft kidnapped, tortured, and murdered at least sixteen men and boys, but the real number of victims is believed to be considerably higher. When he was arrested in 1983, investigators searched Kraft's home and found a list with cryptic references to what they believed were sixty-one victims in total. The discovery of that list led the press to dub Kraft “The Scorecard Killer.”Following his arrest in 1983, Randy Kraft was tried and convicted of sixteen counts of first-degree murder and sentenced to death. Although the arrest and trial put an end to Kraft's murder spree, several critical questions remain unanswered, including the most important aspect of the case detectives were never able to solve: who was Randy Kraft's accomplice?Thank you to the Incredible Dave White of Bring Me the Axe Podcast for research and Writing support!ReferencesArnold, Roxane, and Jerry Hicks. 1983. "Kraft suspected in deaths of 14 men in 3 states, Gates says." Los Angeles Times, May 20: 73.Associated Press. 1983. "Five murders charged to computer analyst." Sacramento Bee, May 25: 2.—. 1978. "Police seek link in deaths of 18." San Bernardino County Sun, November 24: 3.—. 1983. "Freeway killing pattern repeats." The Tribune (San Luis Obispo, CA), February 19: 2.Bajko, Matthew. 2016. Gay serial killer breaks silence. November 2. Accessed May 15, 2025. https://www.ebar.com/story/246748.Grant, Gordon. 1983. "How a routine stop led to a big arrest." Los Angeles Times, May 20: 73.Hicks, Jerry. 1988. "Alleged 'death list' made public as Kraft trial opens." Los Angeles Times, September 27: 69.—. 1989. "Kraft condemned to death by jury for serial killings." Los Angeles Times, August 12: 1.—. 1988. "Kraft defense says marine found in car was not dead." Los Angeles Times, September 28: 76.—. 1989. "Kraft guilty of 16 sex slayings, jury decides." Los Angeles Times, May 13: 1.—. 1989. "Orange County jury gets Kraft serial murder case." Los Angeles Times, April 28: 76.—. 1988. "Two other states were closing in on Kraft." Los Angeles Times, January 4: 3.—. 1989. "Witness says Kraft drugged and sexually assaulted him in 1970." Los Angeles Times, June 6: 3.Hughes, Beth. 1982. "L.A. area's missing youths-a trail of mystery and murder." San Francisco Examiner, August 23: B5.Jarlson, Gary. 1983. "Suspect in 4 slayings also investigated in 6 Oregon murders." Los Angeles Times, May 19: 80.Kennedy, J. Michael. 1978. "Four deaths turn into four mysteries." Los Angeles Times, September 2: 17.Los Angeles Times. 1973. "Head of a man found in a bag at paper plant." Los Angeles Times, April 27: 23.—. 1988. "Randy Kraft's scorecard?" Los Angeles Times, October 2: 117.McDougal, Dennis. 1991. Angel of Darkness: The True Story of Randy Kraft and the Most Heinous Murder Spree. New York, NY: Warner Books. Stay in the know - wondery.fm/morbid-wondery.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Doctors Lisa and Sara are joined by Medical Microbiology and Infectious Diseases Consultant Dr Callum Mutch for an overview of Antibiotics and Microbiology in General Practice. Doctors Callum and Jame host a podcast in Infectious Diseases called ID:IOTS and we wanted to do a crossover episode exploring common themes in Microbiology that we encounter in General Practice. We talk about the case of a woman with recurrent UTIs and a man with epididymo-orchitis. This lends itself to a discussion on general approaches to cases, microbes and antibiotics. We cover a little bit about antimicrobial stewardship at the end.    You can use these podcasts as part of your CPD - we don't do certificates but they still count :) Resources: Podcast: Infectious Diseases Insight of Two Specialists (ID:IOTS): https://www.britishinfection.org/education-events/idiots-podcast Antimicrobial Counselling Resources from Public Health Wales: https://phw.nhs.wales/services-and-teams/antibiotics-and-infections/harp-news/eaadwaaw-2021/resources/community-pharmacy-counselling-checklist/ Antimicrobial Counselling RCGP TARGET Resources: https://elearning.rcgp.org.uk/mod/book/view.php?id=12647 The Cynefin Framework for looking at decisions (Simple, complicated, Complex, Chaos): https://thecynefin.co/about-us/about-cynefin-framework/?srsltid=AfmBOopHNprchcOsISLVvXm2C5W-UU-oqHDkty_jo1IAAsupfoMu4_Cx Shared Decision Making Tool BRAN - Benefits, Risks, Alternatives, Nothing: https://www.england.nhs.uk/personalisedcare/shared-decision-making/decision-support-tools/how-to-use-a-decision-support-tool/#:~:text=Prepare%20patients%20to%20share%20decisions&text=In%20addition%20to%20the%20proactive,Nothing)%20or%20equivalent%20local%20initiatives World Health Organisation AWaRe Book: Access, Watch, Reserve Antimicrobial Book (can aid in decision making around which antibiotics to use. Accessed May 2025):  https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2022.02 UK Health Security Agency Adaptation of the Access, Watch, Reserve (AWaRe) Guidelines: https://www.gov.uk/government/publications/uk-aware-antibiotic-classification/uk-access-watch-reserve-and-other-classification-for-antibiotics-uk-aware-antibiotic-classification ___ We really want to make these episodes relevant and helpful: if you have any questions or want any particular areas covered then contact us on Twitter @PCKBpodcast, or leave a comment on our quick anonymous survey here: https://pckb.org/feedback Email us at: primarycarepodcasts@gmail.com ___ This podcast has been made with the support of GP Excellence and Greater Manchester Integrated Care Board. Given that it is recorded with Greater Manchester clinicians, the information discussed may not be applicable elsewhere and it is important to consult local guidelines before making any treatment decisions.  The information presented is the personal opinion of the healthcare professional interviewed and might not be representative to all clinicians. It is based on their interpretation of current best practice and guidelines when the episode was recorded. Guidelines can change; To the best of our knowledge the information in this episode is up to date as of it's release but it is the listeners responsibility to review the information and make sure it is still up to date when they listen. Dr Lisa Adams, Dr Sara MacDermott and their interviewees are not liable for any advice, investigations, course of treatment, diagnosis or any other information, services or products listeners might pursue as a result of listening to this podcast - it is the clinicians responsibility to appraise the information given and review local and national guidelines before making treatment decisions. Reliance on information provided in this podcast is solely at the listeners risk. The podcast is designed to be used by trained healthcare professionals for education only. We do not recommend these for patients or the general public and they are not to be used as a method of diagnosis, opinion, treatment or medical advice for the general public. Do not delay seeking medical advice based on the information contained in this podcast. If you have questions regarding your health or feel you may have a medical condition then promptly seek the opinion of a trained healthcare professional.

This special vodcast series provided by The Center for Biosimilars® was developed in partnership with the AAM and Biosimilars Council. Check out part 1 of the series featuring a discussion between Giuseppe Randazzo and Craig Burton, former executive director of the Biosimilars Council and current senior vice president of government affairs and policy at Fresenius Kabi. References Jeremias S. The Biosimilar Void: 90% of Biologics Coming Off Patent Will Lack Biosimilars. February 5, 2025. Accessed May 3, 2025. https://www.centerforbiosimilars.com/view/the-biosimilar-void-90-of-biologics-coming-off-patent-will-lack-biosimilars

On the afternoon of June 19, 1994, thirteen-year-old Nicholas Barclay left his home in San Antonio, Texas to play basketball with some friends. Hours later, he called home to ask his mother for a ride, but was told he would have to walk home, but Nicholas never came back. His mother reported him missing and an investigation was started, but it quickly stalled when there was no evidence of what happened to Nicholas.Three years passed and one day, out of the blue, the family received a call from the US Embassy. Nicholas had been discovered in Spain, they said. He had endured terrible trauma at the hands of a human trafficking ring and he was desperate to come home. The family was elated and eagerly welcomed Nicholas back into their home. But to some of the people involved in the boy's return to Texas, there were just too many things about his story that didn't quite add up.Thank you to the Incredible Dave White of Bring Me the Axe Podcast for research and Writing support!ReferencesAssociated Press. 1998. "Fugitive poses as teenager." Orange Leader (Orange, TX), September 12: 5.Davies, Nick. 1998. "The Lost boy." The Guardian, October 17.Flynn, Sheila. 2023. A French serial imposter convinced everyone he was a missing Texas teen. This PI convinced him to confess. January 27. Accessed May 24, 2025. https://www.independent.co.uk/news/world/americas/imposter-netflix-frederic-bourdin-nicholas-barclay-b2269897.html.Grann, David. 2008. "The Chaemeleon." New Yorker, August 8.2012. The Imposter. Directed by Bart Layton. Performed by Bart Layton.Stay in the know - wondery.fm/morbid-wondery.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On the evening of May 10, 1988, a passing driver on Howard Street in Brockton, MA, stopped to investigate something unusual on the side of the road. When the driver got closer to what they thought was a bag, they realized it was actually the body of twenty-four-year-old Anthony LoConte, bleeding badly from injuries to his face and head.Initially, investigators believed LoConte was the victim of a hit-and-run accident; however, when the coroner examined the body, he discovered a bullet hole in the back of LoConte's head, indicating that he'd been murdered.It took twelve years for investigators to track down LoConte's killer, but in the winter of 2000, California Highway Patrol arrested Robert Morganti on drug charges and a quick background check connected them to a 1988 warrant for Morganti for the murder of Anthony LoConte. Robert Morganti was extradited back to Massachusetts, where he was tried, convicted, and sentenced to life in prison without the possibility of parole for LoConte's murder. However, due to a controversial 2024 law concerning life sentences for young offenders, Robert Morganti could be granted parole in the near future.Consider signing the petition by visiting https://www.change.org/p/help-uncle-tony-uphold-mandatory-life-sentences-in-massachusetts-bill-s942 .Thank you to the Incredible Dave White of Bring Me the Axe Podcast for research and Writing support!ReferencesBoston Globe. 1988. "Police believe drugs are linked to slaying of Brockton man." Boston Globe, May 12: 35.Boyle, Maureen. 2000. "Murder suspect caught in Calif." The Enterprise (Brockton, MA), March 21: 1.Commonwealth of Massachusetts v. Robert J. Morganti. 2009. SJC-09830 (Supreme Judicial Court of Massachusetts, Plymouth, November 25).Commonwealth of Massachusetts v. Robert J. Morganti. 2014. SJC-11281 (Massachusetts Supreme Judicial Court, February 12).Peterson, Dave. 2000. "Murder suspect's long flght ends in Modesto." Modesto Bee, March 21: 1.Stern, Amelia. 2025. 'No remorse': Taunton woman devastated by ruling that could free her brother's killer. April 25. Accessed May 04, 2025. https://www.tauntongazette.com/story/news/courts/2025/04/25/taunton-ma-brockton-anthony-loconte-murder-victim-sjc-robert-morganti-parole/83271252007/.Stay in the know - wondery.fm/morbid-wondery.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode 192: ADHD Treatment.  Jordan Redden (MSIV) explains the treatment of ADHD. Dr. Bustamante adds input about pharmacologic and non-pharmacologic treatments. Dr. Arreaza shares the how stimulants were discovered as the treatment for ADHD. Written by Jordan Redden, MSIV, Ross University School of Medicine. Comments and edits by Isabelo Bustamante, MD, and Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Introduction.ADHD is a chronic neurodevelopmental condition characterized by inattention, impulsivity, and/or hyperactivity. While it's often diagnosed in childhood, symptoms can persist well in adulthood. The treatment for ADHD is multifaceted. It often includes medication, behavioral therapy, environmental modifications, and sometimes educational interventions which are especially effective in younger patients. Ongoing evaluation is needed during treatment. Treatment needs adjustments over time.Starting with medications: Stimulants are the most well-studied and effective pharmacologic treatment for ADHD. These include methylphenidate-based medications such as Ritalin, Concerta, and Focalin, and amphetamine-based options, like Adderall, Vyvanse, and Dexedrine. Discovery of stimulants for ADHD> Dr. Charles Bradley discovered stimulants as the treatment for ADHD around 1937. ADHD did not have a name at that time, but it was known that some children had behavioral problems related to poor attention and inability to control their impulses, but they were still intelligent. Dr. Bradley was a psychiatrist who was working in the Bradley Hospital (Rhode Island), he was studying these children and, as part of his experiments, they developed severe headaches. He gave “Benzedrine” (a decongestant) to his pediatric patients to treat severe headaches, and he discovered that Benzedrine improved academic performance and interest in school and improved disruptive behavior in some children.How do stimulants work.Stimulants work primarily by increasing dopamine and norepinephrine levels in the brain, which helps improve focus, attention span, and impulse control. They typically show a rapid onset of action and can lead to noticeable improvements within the first few days of use. Dosing is individualized and should start low with gradual titration. Side effects can include reduced appetite, insomnia, headaches, increased heart rate, and emotional lability.Types of stimulants. Stimulants come as short acting and long acting. They can come as a tablet, liquid, patch, or orally disintegrating tablet. After the discovery of Benzedrine as a possible treatment for ADHD, more research was done over the years, and Ritalin became the first FDA-approved medication for ADHD (1955). The list of medications may seem overwhelming, but there are only two types of stimulants used to treat ADHD: methylphenidate and amphetamine. Long-acting stimulant medications are often preferred for their consistent symptom control and lower potential for misuse. Vyvanse (lis-dexa-mfetamine) is a widely used long-acting amphetamine-based option. As a prodrug, it remains inactive until metabolized in the body, which results in a smoother onset and offset of action and may reduce the risk of abuse. This extended duration of effect can help patients maintain focus and regulate impulses throughout the day without the peaks and crashes sometimes seen with shorter-acting formulations. Of note, Vyvanse is also approved for Binge Eating Disorder. Many of these medications are Schedule II controlled substances, so to prescribe them you need a DEA license. Other long-acting options include Concerta, an extended-release methylphenidate, as well as extended-release versions of Adderall and Focalin. These are especially helpful for school-aged children who benefit from once-daily dosing, and for adults who need sustained attention during work or academic activities. The choice between short- and long-acting stimulants depends on individual response, side effect tolerance, and daily routine.For patients who cannot tolerate stimulants, or for those with contraindications such as a history of substance misuse or certain cardiac conditions, non-stimulant medications are an alternative. One of the most used is atomoxetine, which inhibits the presynaptic norepinephrine transporter (NET). This leads to increased levels of norepinephrine (and to a lesser extent dopamine). Guanfacine or clonidine are alpha-2A adrenergic receptor agonists that lead to reduced sympathetic outflow and enhanced prefrontal cortical function, improving attention and impulse control. These alpha agonists are particularly useful in younger children with significant hyperactivity or sleep disturbances.Non-pharmacologic treatments.Behavioral therapy before age 6 is the first choice, after that, medications are more effective than BH only, and as adults again you use CBT.Medication is often just one part of a broader treatment plan. Behavioral therapy, especially in children, plays a critical role. Parent-training programs, positive reinforcement systems, and structured routines can significantly improve functioning. And for adolescents and adults, cognitive-behavioral therapy (CBT) is particularly helpful. CBT can address issues like procrastination, time management, emotional regulation, and self-esteem which are areas that medication doesn't always touch.Using medications for ADHD can be faced with resistance by parents, and even children. There is stigma and misconceptions about mental health, there may be concerns about side effects, fear of addiction, negative past experiences, and some parents prefer to treat ADHD the “natural” way without medications or only with supplements. All those concerns are valid. Starting a medication for ADHD is the first line of treatment in children who are 6 years and older, but it requires a shared decision with parents and patients. Cardiac side effects are possible with stimulants. EKG may be needed before starting stimulants, but it is not required. Get a personal and family cardiac history, including a solid ROS. Benefits include control of current condition and treating comorbid conditions.The presentation of ADHD changes as the person goes through different stages of life. For example, you may have severe hyperactivity in your school years, but that hyperactivity improves during adolescence and impulsivity worsens. It varies among sexes too. Women tend to present as inattentive, and men tend to be more hyperactive. ADHD is often underdiagnosed in adults, yet it can significantly impact job performance, relationships, and mental health. In adults, we often use long-acting stimulants to minimize the potential for misuse. And psychotherapy, particularly CBT or executive functioning coaching, can be life-changing when combined with pharmacologic treatment. There are several populations where treatment must be tailored carefully such as pregnant patients, individuals with co-occurring anxiety or depression, and those with a history of substance use. For example, atomoxetine may be preferred in patients with a history of substance misuse. And in children with coexisting oppositional defiant disorder, combined behavioral and pharmacologic therapy is usually more effective than either approach alone.Comorbid conditions.Depression and anxiety can be comorbid, and they can also mimic ADHD. Consult your DSM-5 to clarify what you are treating, ADHD vs depression/anxiety.Treatment goes beyond the clinic. For school-aged children, we often work closely with schools to implement 504 plans or Individualized Education Programs (IEPs) that provide classroom accommodations. Adults may also benefit from workplace strategies like structured schedules, noise-reducing headphones, or even coaching support. Ongoing monitoring is absolutely essential. We assess side effects of medication, adherence, and symptom control. ***In children, we also monitor growth and sleep patterns. We often use validated rating scales, like the Vanderbilt questionnaire for children 6–12 (collect answers from two settings) or Conners questionnaires (collect from clinician, parents and teachers), to track progress. And shared decision-making with patients and families is key throughout the treatment process.To summarize, ADHD is a chronic but manageable condition. Effective treatment usually involves a combination of medication and behavioral interventions, tailored to the individual's needs. And early diagnosis and treatment can significantly improve quality of life academically, socially, and emotionally.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., text rev. (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022. CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder). Understanding ADHD. Accessed May 2025. https://chadd.org National Institute for Health and Care Excellence (NICE). Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE guideline [NG87]. Updated March 2018. Accessed May 2025. https://www.nice.org.uk/guidance/ng87 Pliszka SR; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921. doi:10.1097/chi.0b013e318054e724 Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144(4):e20192528. doi:10.1542/peds.2019-2528 Texas Children's Hospital. ADHD Provider Toolkit. Baylor College of Medicine. Accessed May 2025. https://www.bcm.edu Wolraich ML, Hagan JF Jr, Allan C, et al. Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis. UpToDate. Published 2024. Accessed May 2025.https://www.uptodate.comThe History of ADHD and Its Treatments, https://www.additudemag.com/history-of-adhd/Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

In this episode Kelsie and the RHP Director of Research, Jacqui Nelson, discuss the echoes of Nazi fascism and misogyny in modern society. They discuss the role misogyny plays in authoritarianism and the Lebensborn program. History doesn't repeat, it echoes. Let's get into this. Allen, Ann Taylor. "Feminism, Venereal Diseases, and the State in Germany, 1890–1918." Journal of the History of Sexuality 4, no. 1 (1993): 27–50. https://www.jstor.org/stable/3173945.United States Holocaust Memorial Museum. "Lebensborn Program." Holocaust Encyclopedia. Accessed May 21, 2025. https://encyclopedia.ushmm.org/content/en/article/lebensborn-program.Get ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠FREE Learning Materials⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.remedialherstory.com/learn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Support the ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Remedial Herstory Project⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.remedialherstory.com/giving⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SHOP ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Remedial Herstory Gear⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.remedialherstory.com/store⁠⁠⁠⁠⁠Host: Kelsie Eckert and Brooke SullivanEditor: Tyler CardwellProducer: Haley Brook

REFERENCE Jeremias S. The Biosimilar Void: 90% of Biologics Coming Off Patent Will Lack Biosimilars. February 5, 2025. Accessed May 3, 2025. https://www.centerforbiosimilars.com/view/the-biosimilar-void-90-of-biologics-coming-off-patent-will-lack-biosimilars

Orthostatic vitals are taught throughout medical training as a quick and easy way to assess patient volume status objectively. We also frequently see these documented in MCHD charts. Is there any evidence that orthostatics help our clinical decision-making? Has anyone ever evaluated their use in EMS? Could standing a patient to check their heart rate actually be harmful? Join the podcast crew as they address these questions and more. REFERENCES 1. White, JL, Hollander, JE, Chang, AM, et al. (2019). Orthostatic vital signs do not predict 30-day serious outcomes in older emergency department patients with syncope: A multicenter observational study. The American journal of emergency medicine, 37(12), 2215–2223. 2. Shen W, Sheldon R, Yancy C, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of The American College Of Cardiology. August 1, 2017;70(5):e39-e110. Available from: MEDLINE, Ipswich, MA. Accessed May 1, 2018. 3. Cohen E, Grossman E, Sapoznikov B, et al. Assessment of orthostatic hypotension in the emergency room. Blood Press. 2006;15(5):263-267. 4. Aronow WS, Lee NH, Sales FF, Etienne F. Prevalence of postural hypotension in elderly patients in a long-term health care facility. Am J Cardiol. 1988;62(4):336. 5. Ooi WL, Barrett S, Hossain M, et al. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population. JAMA. 1997;277(16):1299-1304.

Joining us for this episode of Feedstuffs in Focus is Dr. David Baumert, Senior Technical Services Veterinarian at Zoetis Pork, to discuss the reasons why producers sometimes choose not to treat pigs — usually heavier weight finishers — in need of swine respiratory disease (SRD) therapy and the implications of non-use from a performance, labor and economic standpoint. This episode of Feedstuffs in Focus has been brought to you by Zoetis Pork.IMPORTANT SAFETY INFORMATION: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCENEL RTU EZ. Do not use in swine found to be hypersensitive. Withdraw 6 days prior to slaughter when injection site volumes are greater than 5 mL up to 15 mL per injection site and 4 days prior to slaughter when injection site volumes are less than or equal to 5 mL per injection site. See full Prescribing Information at Excenelpork.com/PI.ReferencesPantoja L, Kuhn M, Farrand E, et al. Impact of a Husbandry Education Program on nursery pig mortality, productivity, and treatment cost. Journal of Swine Health and Production [serial online]. 2013;21 (4):188-194. Available from: CAB Abstracts, Ipswich, MA. Accessed May 1, 2018. Pineiro C, Morales J, Doncecchi P, et al. Individual Pig Care program improves productive performance and animal health in nursery-growing pigs. Journal of Swine Health and Production [serial online]. 2014;22 (6):296-299. Available from: CAB Abstracts, Ipswich, MA. Accessed August 1, 2018.Bowersock, T. L., Meeuwse, D. M., Kausche, F. M., Lucas, M. J., Bryson, W. L. and Dame, K.J. Efficacy of ceftiofur crystalline free acid and ceftiofur hydrochloride administered intramuscularly in swine inoculated with Actinobacillus pleuropneumoniae. Pharmacia Animal Health. 2001. Data on file, Study Document No. ZRD-PSC-004402, Zoetis Inc.All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. © 2024 Zoetis Services LLC. All rights reserved. EXC-00084

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-396 Overview: Listen in as we discuss the health risks of e-cigarette use and dual use, emphasizing the importance of primary prevention and supporting patients in their cessation efforts. Discover the latest evidence on vaping's impact on addiction, cardiovascular health, and lung cancer, and gain essential insights to better advise your patients. Episode resource links: Bittoni MA, et al. Abstract 2213. Presented at: American Association for Cancer Research Annual Meeting; April 5-10, 2024; San Diego. (AACR 2024: Ohio State experts share new findings at annual meeting (press release). Available at: https://cancer.osu.edu/news/aacr-2024-ohio-state-experts-share-new-findings. Posted April 5,2024. Accessed May 3, 2024.) Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5 Hopkinson NS, et al "Association of time spent on social media with youth cigarette smoking and e-cigarette use in the UK: a national longitudinal study" Thorax 2024: DOI:10.1136/ thorax-2023-220569. Y.W. Kim, E.J. Park, K.I. Kwak, A.-R. Choi, B.J. Lee, Y.J. Lee, J.S. Park, Y.-J. Cho, J.H. Lee, and C.-T. Lee. Association of Electronic Cigarette Use After Conventional Smoking Cessation With Lung Cancer Risk: A Nationwide Cohort Study (abstract). Am J Respir Crit Care Med 2024;209:A3051. CDC: Health Effects of Vaping; https://www.cdc.gov/tobacco/e-cigarettes/health-effects.html CDC:Dual Use of Tobacco Products; https://www.cdc.gov/tobacco/campaign/tips/diseases/dual-tobacco-use.html Guest: Susan Feeney, DNP, FNP-BC, NP-C  Music Credit: Richard Onorato Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-396 Overview: Listen in as we discuss the health risks of e-cigarette use and dual use, emphasizing the importance of primary prevention and supporting patients in their cessation efforts. Discover the latest evidence on vaping's impact on addiction, cardiovascular health, and lung cancer, and gain essential insights to better advise your patients. Episode resource links: Bittoni MA, et al. Abstract 2213. Presented at: American Association for Cancer Research Annual Meeting; April 5-10, 2024; San Diego. (AACR 2024: Ohio State experts share new findings at annual meeting (press release). Available at: https://cancer.osu.edu/news/aacr-2024-ohio-state-experts-share-new-findings. Posted April 5,2024. Accessed May 3, 2024.) Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5 Hopkinson NS, et al "Association of time spent on social media with youth cigarette smoking and e-cigarette use in the UK: a national longitudinal study" Thorax 2024: DOI:10.1136/ thorax-2023-220569. Y.W. Kim, E.J. Park, K.I. Kwak, A.-R. Choi, B.J. Lee, Y.J. Lee, J.S. Park, Y.-J. Cho, J.H. Lee, and C.-T. Lee. Association of Electronic Cigarette Use After Conventional Smoking Cessation With Lung Cancer Risk: A Nationwide Cohort Study (abstract). Am J Respir Crit Care Med 2024;209:A3051. CDC: Health Effects of Vaping; https://www.cdc.gov/tobacco/e-cigarettes/health-effects.html CDC:Dual Use of Tobacco Products; https://www.cdc.gov/tobacco/campaign/tips/diseases/dual-tobacco-use.html Guest: Susan Feeney, DNP, FNP-BC, NP-C  Music Credit: Richard Onorato Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  

It's Pride Month, and I thought what a great time to talk about the other half of one of the most infamous pirate duos in history: pirate queen Mary Read. We don't know a ton for sure about Mary's life before she became a pirate. However, we do know that Mary had wild adventures disguised as a boy in the military before she ever took up a life of privacy with her girlfriend, Anne Bonney and Anne Bonney's boyfriend, Jack Rackham. Join me on this episode to learn the wild tale of how a less than half-a-year private career made Mary the most famous female pirate in history. Bibliography Abbott, Karen. “If There's a Man Among Ye: The Tale of Pirate Queens Anne Bonny and Mary Read.” Smithsonian Magazine, August 9, 2011. https://www.smithsonianmag.com/history/if-theres-a-man-among-ye-the-tale-of-pirate-queens-anne-bonny-and-mary-read-45576461/. Cartwright, Mark. “Calico Jack.” World History Encyclopedia. Accessed May 18, 2024. https://www.worldhistory.org/Calico_Jack/. ———. “Mary Read.” World History Encyclopedia. Accessed May 18, 2024. https://www.worldhistory.org/Mary_Read/. Contributors to Wikimedia projects. “Mary Read.” Wikipedia, May 12, 2024. https://en.wikipedia.org/wiki/Mary_Read. “Early Life · Mary Read and Anne Bonny: Two of England's Most Notorious Pirates · Gallery.” Accessed May 18, 2024. https://gallery.lib.umn.edu/exhibits/show/mary-read-anne-bonny/mary-read/mary-read--early-life. Pirates! Fact and Legend. “Life in a Man's World: Mary Read.” Accessed May 18, 2024. https://www.piratesinfo.com/famous-pirates/mary-read/life-in-a-mans-world-mary-read/. Historic UK. “Mary Read the Pirate,” September 3, 2017. https://www.historic-uk.com/HistoryUK/HistoryofEngland/Mary-Read-Pirate. Minster, Christopher. “Biography of Mary Read, English Pirate.” ThoughtCo, February 8, 2011. https://www.thoughtco.com/biography-of-mary-read-2136221. Queen Anne's Revenge Project. “Pirate Profile: Mary Read.” Accessed May 18, 2024. https://www.qaronline.org/blog/2020-03-15/pirate-mary-read. Simon, Rebecca Alexandra. Pirate Queens: The Lives of Anne Bonny & Mary Read. Pen and Sword History, 2022. “The Project Gutenberg eBook of The Pyrates, by Daniel Defoe.” Accessed May 18, 2024. https://www.gutenberg.org/files/40580/40580-h/40580-h.htm. Tikkanen, Amy. “Mary Read.” Encyclopedia Britannica, August 2, 2017. https://www.britannica.com/biography/Mary-Read.

The Missouri Leviathan was an enormous skeleton made of fossilized bones that were excavated and assembled by Albert C. Koch. Was it a hoax, or just bad science?  Research:  Lotzof, Kerry. “Missouri Leviathan: the making of an American mastodon.” Natural History Museum (London). https://www.nhm.ac.uk/discover/the-making-of-an-american-mastodon.html Wanko, Andrew. “Great River City: The Missouri Leviathan.” Missouri Historical Society. 12/12/2019. https://mohistory.org/blog/great-river-city-the-missouri-leviathan Missouri State Parks. “At Mastodon State Historic Site.” https://mostateparks.com/page/54983/historic-site-history Phillips, Nicholas. “This odd creature from Missouri once gained international fame.” St. Louis Magazine. 5/8/2020. https://www.stlmag.com/culture/missouri-leviathan-albert-koch-mastodon-kimmswick/ Ashworth, William. “Scientist of the Day: Albert C. Koch.” Linda Hall Library. 5/10/2022. https://www.lindahall.org/about/news/scientist-of-the-day/albert-c-koch/ Mackenthun, Gesa. “Albert Koch.” Universitat Rostock. 3/4/2016. https://www.iaa.uni-rostock.de/forschung/laufende-forschungsprojekte/american-antiquities-prof-mackenthun/project/agents/albert-c-koch/ Buckley, S.B. “On the Zeuglodon Remains of Alabama.” American Journal of Science and Arts, Band 52. Dana, James D. “On Dr. Koch's Evidence with Regard to the Cotemporaneity of Man and the Mastodon in Missouri.” American Journal of Science and the Arts, Vol. IX, May 1875. Hoy, P.R. “Dr. Koch's Missorium.” The American Naturalist Volume 5, Issue 3. May, 1871. https://doi.org/10.1086/270728 Krause, Stefan. “From Prehistory to Deep History: The Coloniality of Counting Time.” Universitat Rostock. Proceedings of the Geological Society of London. Vol. 3, Part 2. No. 87. 1842. Hensley, John R. “Transactions of the Academy of Science of St. Louis.” Vol. 33, No. 1. McMillan, R. Bruce. “Objects of Curiosity: Albert Koch's `1840 St. Louis Museum.” The Living Museum vol. 42, no. 02,03; 1980. Via Illinois Digital Archives. McMillan, R. Bruce. “More than a Fossil Hunter: The Life and Pursuits of Charles W. Beehler.” The Confluence. Spring/Summer 2013. Hazen, Robert M. "Phenomena, comment and notes." Smithsonian, vol. 22, no. 7, Oct. 1991, pp. 28+. Gale In Context: U.S. History, link.gale.com/apps/doc/A11373982/GPS?u=mlin_n_melpub&sid=bookmark-GPS&xid=99bffd4a. Accessed 22 May 2024. Bruce Mcmillan, R. "ALBERT C. KOCH'S MISSOURIUM AND THE DEBATE OVER THE CONTEMPORANEITY OF HUMANS AND THE PLEISTOCENE MEGAFAUNA OF NORTH AMERICA." Earth Sciences History, vol. 41, no. 2, July 2022, pp. 410+. Gale In Context: Science, dx.doi.org/10.17704/1944-6187-41.2.410. Accessed 22 May 2024. Mcmillan, R. Bruce. "ALBERT KOCH'S HYDRARCHOS: A HOAX OR A BONA FIDE COLLECTION OF BONES." Earth Sciences History, vol. 42, no. 1, Jan. 2023, pp. 84+. Gale In Context: Science, dx.doi.org/10.17704/1944-6187-42.1.84. Accessed 22 May 2024. Rieppel, Lukas. “Albert Koch's Hydrarchos Craze: Credibility, Identity, and Authenticity in Nineteenth-Century Natural History.” From: Science Museums in Transition: Cultures of Display in Nineteenth-Century Britain and America. 1 ed. University of Pittsburgh Press, 2017. muse.jhu.edu/book/52515 Koch, Albert C. “Description of Missourium, or Missouri leviathan : together with its supposed habits and Indian traditions concerning the location from whence it was exhumed; also, comparisons of the whale, crocodile and missourium with the leviathan, as described in 41st chapter of the book of Job.” Louisville, Ky. : Prentice and Weissinger. 1841. “The Missourium.” The Farmers' Cabinet and American Herd-Book : Devoted to Agriculture, Horticulture, and Rural and Domestic Affairs 1841-12-15: Vol 6 Iss 5. Veit, Richard. "Mastodons, Mound Builders, and Montroville Wilson Dickeson–Pioneering American Archaeologist." Expedition Magazine 41, no. 3 (November, 1999): -. Accessed May 24, 2024. https://www.penn.museum/sites/expedition/mastodons-mound-builders-and-montroville-wilson-dickeson-pioneering-american-archaeologist/ See omnystudio.com/listener for privacy information.

Two common questions we receive are: "Does my weight affect health?" and "Is fat bad?". In today's episode, Abbey brings in the research to answer these questions. And, as always, brings in a wee bit of humor and poor singing. JOIN the Fork Diet Culture Community! - Get access to the rest of this 40 minute video, more individualized support from Abbey, connect with like-minded people, and more! Mention: Episode 04: BMI Is Bizarre and Icky. Work with us 1-on-1 More about Abbey and the team References: Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013;309(1):71-82. doi:10.1001/jama.2012.113905 Flegal, K., The obesity wars and the education of a researcher: A personal account, Progress in Cardiovascular Diseases, Volume 67, 2021,Pages 75-79, ISSN 0033-0620, https://doi.org/10.1016/j.pcad.2021.06.009. (https://www.sciencedirect.com/science/article/pii/S0033062021000670) Flegal KM, Ioannidis JPA, Doehner W. Flawed methods and inappropriate conclusions for health policy on overweight and obesity: the Global BMI Mortality Collaboration meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10(1):9-13. doi:10.1002/jcsm.12378 Tobias DK, Hu FB. Does being overweight really reduce mortality?. Obesity (Silver Spring). 2013;21(9):1746-1749. doi:10.1002/oby.20602 Heymsfield SB, Cefalu WT. Does Body Mass Index Adequately Convey a Patient's Mortality Risk? JAMA. 2013;309(1):87–88. doi:10.1001/jama.2012.185445 Gibbs W. Obesity: An Overblown Epidemic? . https://www.scientificamerican.com/article/obesity-an-overblown-epidemic-2006-12/ Web site. . Updated 2024. Accessed May 18, 2024 Humphreys S. The unethical use of BMI in contemporary general practice. Br J Gen Pract. 2010;60(578):696-697. doi:10.3399/bjgp10X515548 Luli M, Yeo G, Farrell E, et al. The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conference. EClinicalMedicine. 2023;58:101962. Published 2023 Apr 6. doi:10.1016/j.eclinm.2023.101962 Tylka TL, Annunziato RA, Burgard D, et al. The weight-inclusive versus weight-normative approach to health: evaluating the evidence for prioritizing well-being over weight loss. J Obes. 2014;2014:983495. doi:10.1155/2014/983495

Welcome to Episode 36 of “The 2 View,” the podcast for EM and urgent care nurse practitioners and physician assistants! Show Notes for Episode 36 of “The 2 View” – Marijuana as a schedule III drug, treating sunburns and other skin problems, pulse oximetry and racial bias, and diagnosing lower UTIs. Marijuana as a schedule III drug Burton KW. The DEA Plans to Reschedule Marijuana: What Happens Next? Medscape: Emergency Medicine. Published May 2, 2024. Accessed May 10, 2024. https://www.medscape.com/viewarticle/dea-plans-reschedule-marijuana-what-happens-next-2024a10008ka?ecd=wnledittpal_etid6489685&uac=106964SV&impID=6489685 Dea.gov. DEA: United States Drug Enforcement Administration. Accessed May 10, 2024. https://www.dea.gov/drug-information/drug-scheduling Treating sunburns and other skin problems 12 Summer Skin Problems You Can Prevent. Aad.org. American Academy of Dermatology Association. Accessed May 10, 2024. https://www.aad.org/public/everyday-care/skin-care-secrets/routine/prevent-summer-skin-problems Benedetti J. Sunburn. Merck Manual Professional Edition. Reviewed/Revised Oct 2023. Accessed May 10, 2024. https://www.merckmanuals.com/professional/dermatologic-disorders/reactions-to-sunlight/sunburn Faurschou A, Wulf HC. Topical corticosteroids in the treatment of acute sunburn: A randomized, double-blind clinical trial. Arch Dermatol. PubMed. NIH: National Library of Medicine: National Center for Biotechnology Information. Published May 2008. Accessed May 10, 2024. https://pubmed.ncbi.nlm.nih.gov/18490588/ How to Treat Sunburn. Aad.org. American Academy of Dermatology Association. Accessed May 10, 2024. https://www.aad.org/public/everyday-care/injured-skin/burns/treat-sunburn Skowrońska W, Bazylko A. The Potential of Medicinal Plants and Natural Products in the Treatment of Burns and Sunburn—A Review. Pharmaceutics. PMC: PubMed Central. NIH: National Library of Medicine: National Center for Biotechnology Information. Published February 2023. Accessed May 10, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958865/ Pulse oximetry and racial bias Gudelunas MK, Lipnick M, Hendrickson C, et al. Low Perfusion and Missed Diagnosis of Hypoxemia by Pulse Oximetry in Darkly Pigmented Skin: A Prospective Study. Anesth Analg. PubMed. NIH: National Library of Medicine: National Center for Biotechnology Information. Published March 1, 2024. Accessed May 10, 2024. https://pubmed.ncbi.nlm.nih.gov/38109495/ Valbuena VSM, Seelye S, Sjoding MW, et al. Racial bias and reproducibility in pulse oximetry among medical and surgical inpatients in general care in the Veterans Health Administration 2013-19: multicenter, retrospective cohort study. BMJ. Published July 6, 2022. Accessed May 10, 2024. https://www.bmj.com/content/378/bmj-2021-069775.long Diagnosing Lower UTIs Aydemir B, Overton D. Diagnosing Lower Urinary Tract Infections. ACEP Now: The Official Voice of Emergency Medicine. Published May 10, 2024. Accessed May 10, 2024. https://www.acepnow.com/article/diagnosing-lower-urinary-tract-infections/ Recurring Sources Center for Medical Education. Ccme.org. http://ccme.org The Proceduralist. Theproceduralist.org. http://www.theproceduralist.org The Procedural Pause. Emergency Medicine News. Lww.com. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx The Skeptics Guide to Emergency Medicine. Thesgem.com. http://www.thesgem.com Trivia Question: Send answers to 2viewcast@gmail.com Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to. Be sure to listen in and see what we have to share!

Welcome to Episode 35 of “The 2 View,” the podcast for EM and urgent care nurse practitioners and physician assistants! Show Notes for Episode 35 of “The 2 View” – the spring editorial edition! POCUS in the ED for Cholecystitis March 2024: Annals of Emergency Medicine. SoundCloud. Published January 2022. Accessed May 2, 2024. https://soundcloud.com/annalsofem/march-2024 The Center for Medical Education. Upper Abdominal Disorders | The EM Boot Camp Course. YouTube. Published July 12, 2022. Accessed May 2, 2024. https://www.youtube.com/watch?v=ESxRdeEYeHk Wilson SJ, Thavanathan R, Cheng W, et al. Test Characteristics of Emergency Medicine-Performed Point-of-Care Ultrasound for the Diagnosis of Acute Cholecystitis: A Systematic Review and Meta-analysis. Ann Emerg Med. Published October 18, 2023. Accessed May 2, 2024. https://www.annemergmed.com/article/S0196-0644(23)01214-3/abstract PECARN Validation Holmes JF, Yen K, Ugalde IT, et al. PECARN prediction rules for CT imaging of children presenting to the emergency department with blunt abdominal or minor head trauma: a multicentre prospective validation study. Lancet Child Adolesc Health. PubMed. NIH: National Library of Medicine: National Center for Biotechnology Information. Published May 2024. Accessed May 2, 2024. https://pubmed.ncbi.nlm.nih.gov/38609287/ PECARN Pediatric Head Injury/Trauma Algorithm. MDCalc. Accessed May 2, 2024. https://www.mdcalc.com/calc/589/pecarn-pediatric-head-injury-trauma-algorithm PECARN Pediatric Intra-abdominal injury (IAI) algorithm. MDCalc. Accessed May 2, 2024. https://www.mdcalc.com/calc/3971/pecarn-pediatric-intra-abdominal-injury-iai-algorithm PECARN Spotlight: Tools Validated. EM Pulse PodcastTM. EM Pulse PodcastTM - Bringing research and expert opinion to the bedside. Published April 18, 2024. Accessed May 2, 2024. https://ucdavisem.com/2024/04/18/pecarn-spotlight-tools-validated/ Recurring Sources Center for Medical Education. Ccme.org. http://ccme.org The Proceduralist. Theproceduralist.org. http://www.theproceduralist.org The Procedural Pause. Emergency Medicine News. Lww.com. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx The Skeptics Guide to Emergency Medicine. Thesgem.com. http://www.thesgem.com Trivia Question: Send answers to 2viewcast@gmail.com Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to. Be sure to listen in and see what we have to share!

In this special Complex Care Journal Club podcast episode, co-hosts Kristie Malik, Emily Goodwin and Kathleen Huth interview presenters of posters and oral abstracts relevant to the care of children with medical complexity at the Pediatric Academic Societies (PAS) 2024 annual meeting. Speakers describe the implications of their study findings, messages for patients and families, and priority areas for research that they hope can be investigated further by the complex care community in the coming years. SPEAKERS Mary Arakelyan, MPH Research Project Manager Dartmouth Health Children's Tammie Dewan, MD, MSc Clinical Assistant Professor Department of Pediatrics, University of Calgary Pediatrician, Alberta Children's Hospital Caleb Easterly, BA MD/PhD Student University of North Carolina School of Medicine Kevin Huynh, MS Medical Student University of Pittsburgh School of Medicine Ruchi Kaushik, MD, MEd, MPH Medical Director of Education and Research Imagine Pediatrics, Houston TX Joanna Leyenaar, MD, PhD Professor, Department of Pediatrics Dartmouth Health Children's Savithri Nageswaran, MD, MPH Professor, Department of Pediatrics Wake Forest University School of Medicine Julia Reedy, MA Qualitative Analyst ACCORDS, University of Colorado S. Margaret Wright, MD, MPH Clinical Assistant Professor of Pediatrics University of Missouri-Kansas City School of Medicine Justin Yu, MD, MS Assistant Professor of Pediatrics UPMC Children's Hospital of Pittsburgh HOSTS Kristina Malik, MD Pediatrician, Special Care Clinic, Children's Hospital Colorado Emily J Goodwin, MD Pediatrician, General Academic Pediatrics Beacon Program Children's Mercy Kansas City Kathleen Huth, MD, MMSc Pediatrician, Complex Care Service, Division of General Pediatrics Boston Children's Hospital DATE Initial publication: May 15, 2024. REFERENCES Fehlings D, Agnew B, Gimeno H, Harvey A, Himmelmann K, Lin JP, Mink JW, Monbaliu E, Rice J, Bohn E, Falck-Ytter Y. Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update. Dev Med Child Neurol. 2024 Apr 19. doi: 10.1111/dmcn.15921. Epub ahead of print. PMID: 38640091. Pediatric Academic Societies. Who we are. Accessed May 6, 2024. https://www.pas-meeting.org/about/ TRANSCRIPT Clinicians across healthcare professions, advocates, researchers, and patients/families are all encouraged to engage and provide feedback! You can recommend an article for discussion using this form: forms.gle/Bdxb86Sw5qq1uFhW6 Please visit: www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access, thus at no expense to the user. For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu CITATION Malik K, Goodwin EJ, Arakelyan M, Dewan T, Easterly C, Huynh K, Kaushik R, Leyenaar J, Nageswaran S, Reedy J, Wright SM, Yu J, Huth K. Practice-Changing Research in Complex Care at the Pediatric Academic Societies 2024 Annual Meeting. 5/2024. OPENPediatrics. Online Podcast. https://soundcloud.com/openpediatrics/practice-changing-research-in-complex-care-at-the-pediatric-academic-societies-2024-annual-meeting

Noah Smith & Brad DeLong Record the Podcast We, at Least, Would Like to Listen to!; Aspirationally Bi-Weekly (Meaning Every Other Week); Aspirationally an hour...Key Insights:* Someone is wrong on the internet! Specifically Brad… He needs to shape up and scrub his brain… * Back in the 2000s, Brad argued that the U.S. should over the next few generations try to pass the baton of world leadership to a prosperous, democratic, liberal China…* Back in the 2000s, Noah thought that Brad was wrong—he looked at the Chinese Communist Party, and he thought: communist parties do not do “coëxistence”…* Noah understands people with a limitless authoritarian desire for power—people like Trump, Xi, Putin, and in the reverse Abe—and the systems that nurture and promote them…* Why did Brad go wrong? Excessive reliance in the deep structures of his brain on the now 60-year-old Social Origins of Dictatorship and Democracy: Lord and Peasant in the Making of the Modern World.* Why did Brad go wrong? A failure to understand Lenin's party of a new type as a bureaucratic-cultural organization…* Suggestions for what Brad DeLong should earn during his forthcoming stint in the reëducation camp are welcome…* &, as always, Hexapodia…References:* Bear, Greg. 1985. Blood Music. New York: Arbor House. .* Brown, Kerry. 2022. Xi: A Study in Power. London: Icon Books..* Cai, Xia. 2022. "The Weakness of Xi Jinping: How Hubris and Paranoia Threaten China's Future." Foreign Affairs. September/October. https://www.foreignaffairs.com/china/xi-jinping-china-weakness-hubris-paranoia-threaten-future.* DeLong, J. Bradford. 2019. "What to Do About China?" Project Syndicate, June 5. .* DeLong, J. Bradford. 2019. "America's Superpower Panic". Project Syndicate, August 14. .* DeLong, J. Bradford. 2023. "Theses on China, the US, Political-Economic Systems, Global Value Chains, & the Relationship". Grasping Reality. Accessed June 19. .* Lampton, David M. 2019. Following the Leader: Ruling China, from Deng Xiaoping to Xi Jinping. Berkeley: University of California Press..* Moore, Barrington, Jr. 1966. Social Origins of Dictatorship and Democracy: Lord & Peasant in the Making of the Modern World. Boston: Beacon Press. .* Pronin, Ivan, & Mikhail Stepichev. 1969. Leninist Standards of Party Life. Moscow: Progress Publishers. .* Sandbu, Martin. 2022. “Brad DeLong: ‘The US is now an anti-globalisation outlier'”. Financial Times. November 23. .* Sasaki, Norihiko. 2023. "Functions and Significance of the Central Leading Group for Comprehensively Deepening Reforms and the Central Comprehensively Deepening Reforms Commission." Chinese Journal of Political Science 28 (3): 1-15. Accessed May 14, 2024. https://www.tandfonline.com/doi/full/10.1080/24761028.2023.2185394.* Shambaugh, David, ed. 2020. China and the World. New York: Oxford University Press. .&* Vinge, Vernor. 1999. A Deepness in the Sky. New York: Tor Books. . Get full access to Brad DeLong's Grasping Reality at braddelong.substack.com/subscribe

Noah Smith & Brad DeLong Record the Podcast We, at Least, Would Like to Listen to!; Aspirationally Bi-Weekly (Meaning Every Other Week); Aspirationally an hour... Key Insights:* Vernor Vinge was one of the GOAT scifi authors—and he is also one of the most underrated…* That a squishy social-democratic leftie like Brad DeLong can derive so much insight and pleasure from the work of a hard-right libertarian like Vernor Vinge—for whom the New Deal Order is very close to being the Big Bad, and who sees FDR as a cousin of Sauron—creates great hope that there is a deeper layer of thought to which we all can contribute. The fact that Brad DeLong and Vernor Vinge get excited in similar ways is a universal force around which we can unite, and add to them H.G. Wells and Jules Verne…* The five things written by Vernor Vinge that Brad and Noah find most interesting are: * “The Coming Technological Singularity: How to Survive in the Post-Human Era”,* A Fire Upon the Deep,* A Deepness in the Sky, * “True Names”, & * Rainbows End…* We do not buy the Supermind Singularity: The world is not a game of chess in which the entity that can think 40 moves ahead will always easily trounce the entity that can only think 10 moves ahead, for time and chance happeneth to us all…* We do not buy the Supermind Singularity: Almost all human intelligence is not in individual brains, but is in the network. We are very smart as an anthology intelligence. Whatever true A.I.s we create will be much smarter when they are tied into the network as useful and cooperative parts of it—rather than sinister gods out on their own plotting plots…* We do not buy the Supermind Singularity: mind and technology amplification is as likely to be logistic as exponential or super-exponential…* The ultimate innovation in a society of abundance is the ability to control human personality and desire—and now we are back to the Buddha, and to Zeno, Kleanthes, Khrisippus, and Marcus Aurelius…* With the unfortunate asterisk that mind-hacking via messages and chemicals mean that such an ultimate innovation can be used for evil as well as good…* Addiction effects from gambling are not, in fact, a good analogy for destructive effects of social media as a malevolent attention-hacker…* Cyberspace is not what William Gibson and Neil Stephenson predicted.But it rhymed. And mechanized warfare was not what H.G. Wells predicted.But it rhymed. A lot of the stuff about AI that we see in science fiction will rhyme with whatever things are going to happen…* The Blight of A Fire Upon the Deep is a not-unreasonable metaphor for social media as propaganda intensifier…* We want the future of the Whole Earth Catalog and the early Wired, not of crypto grifts and ad-supported social media platforms…* Vernor Vinge's ideas will be remembered—if only as important pieces of a historical discussion about why the Superintelligence Singularity road was not (or was) taken—as long as the Thrones of the Valar endure…* Noah Smith continues to spend too much time picking fights on Twitter…* &, as always, Hexapodia…References:* DeLong, J. Bradford. 2022. Slouching Towards Utopia: The Economic History of the 20th Century. New York: Basic Books. .* Bursztyn, Leonardo, Benjamin Handel, Rafael Jiménez-Durán, & Christopher Roth. 2023. “When Product Markets Become Collective Traps: The Case of Social Media”. Becker-Friedman Institute. October 12. .* Patel, Nilay, Alex Cranz, & David Pierce. 2024. “Rabbit, Humane, & the iPad”. Vergecast. May 3. .* MacIntyre, Alasdair. 1966. A Short History of Ethics: : A History of Moral Philosophy from the Homeric Age to the Twentieth Century. New York: Macmillan. .* Ober, Josiah. 2008. Democracy & Knowledge: Innovation & Learning in Classical Athens. Princeton: Princeton University Press. .* Petpuls. 2024. “The World's First Dog Emotion Translator”. Accessed May 7, 2024. .* Rao, Venkatesh. 2022. “Beyond Hyperanthropomorphism”. Ribbonfarm Studio. Auguts 21. .* Taintor, Joseph. 1990. The Collapse of Complex Societies. Cambridge: Cambridge University Press. .* Vinge, Vernor. 1984. “True Names”. True Names & Other Dangers. New York: Bluejay Books. .* Vinge, Vernor. 1992. A Fire Upon the Deep. New York: Tor Books. .* Vinge, Vernor. 1993. "The Coming Technological Singularity: How to Survive in the Post-Human Era". .* Vinge, Vernor. 1999. A Deepness in the Sky. New York: Tor Books. .* Vinge, Vernor. 2006. Rainbows End. New York: Tor Books. .* Williams, Walter Jon. 1992. Aristoi. New York: Tor Books. * Wikipedia. “Vernor Vinge”. Accessed May 7, 2024. . Get full access to Brad DeLong's Grasping Reality at braddelong.substack.com/subscribe

In the 1960s, one hopeful British psychiatrist hoped he could prevent disaster—not with science, but with the supernatural. For a number of years. Dr. John Barker's “Premonition Bureaus” collected psychic visions with a single goal: stopping tragedy before it could strike.  Hosted by Laurah Norton  Researched by Anna Luria  Edited by Laurah Norton and Maura Currie  Produced and Engineered by Maura Currie  Works Cited: Bastian, Jonathan. “Predicting the future: The true story of the Premonitions Bureau.” KCRW [Santa Monica, California], 16 Jul. 2022, Accessed May 2023.  Britannica, The Editors of Encyclopaedia. "Nicosia.” Encyclopedia Britannica, 18 Jan. 2023, Accessed May 2023. Cope, Michael. “Premonition: Royal Family to Face Scandal?” The Des Moines Register, 21 Nov. 1972. Accessed May 2023.  Cummins, Anthony. “The Premonitions Bureau by Sam Knight review - the press, psychiatry and the paranormal.” The Guardian, 03 May 2022. Accessed May 2023.  Freeman, Sue. “A woman's intuition…” Liverpool Echo, 05 Feb. 1973. Accessed May 2023.  Gladstone, Bill. “Future Watch.” The Gazette [Montreal, Canada], 12 Jan. 1980. Accessed May 2023.  Harrison, Dave. “Does Mr. Spock figure in your dreams?” Leicester Chronicle, 01 Jun. 1979. Accessed May 2023.  Irwin, Theodore. “Can Some People See into the FUTURE?” The Pantagraph, 04 May 1969. Accessed May 2023.  Knight, Sam. “The Psychiatrist Who Believed People Could Tell The Future.” The New Yorker, 25 Feb. 2019. Accessed May 2023.  Mail Reporter, Evening. “The ‘early-warning premonition bureau.'” Birmingham Evening Mail, 06 Feb. 1968. Accessed May 2023.  Post Reporter, Birmingham. “A Bureau to avert disasters?” The Birmingham Post, 28 Feb. 1968. Accessed May 2023.  Spraggett, Allen. “Was the premonition a dream or truth?” The Victorian, 06 May 1974. Accessed May 2023.  “4 Britons among 124 dead in plane crash.” Birmingham Evening Mail and Despatch, 20 Apr. 1967, p. 18. Accessed May 2023.  “Hitching Hopes To the Stars.” Muncie Evening Press, 10 Jun. 1969. Accessed May 2023.  “Miss Future…” Evening Post, 06 Feb. 1973. Accessed May 2023.  “Peering into the future - some just have the knack.” Calgary Herald, 13 Dec. 1972. Accessed May 2023.  “Royal Puppies.” Evening Standard [London, Greater London, England], 23 Sep. 1971. Accessed May 2023.  “Soyuz 1.” NASA Space Science Data Coordinated Archive, NASA Official, 28 Oct. 2022. Accessed May 2023.  “The future is theirs to see.” Evening Post, 07 Jan. 1975. Accessed May 2023.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Approximately 9.5% (16,595,00) of American adults aged 18 and over will experience a depressive illness (major depression, bipolar disorder, or dysthymia) each year. Women have nearly twice the likelihood of experiencing major depression compared to men. On the other hand, both men and women have an equal chance of developing bipolar disorder.However, most studies indicate that when Black individuals do experience depression, the condition tends to persist for a longer duration. Additionally, they may have a higher likelihood of co-occurring diagnoses such as addiction, post-traumatic stress disorder, and generalized anxiety disorder.Racism and stigma within the mental health profession can exacerbate the impact of depression. Healthcare professionals and other providers tend to offer lower treatment rates for Black individuals with depression compared to their white counterparts.Sources: "Black Depression." Medical News Today. Accessed May 11, 2023, https://www.medicalnewstoday.com/articles/black-depression.Understanding and Overcoming Impostor Syndrome." Medical News Today. Accessed May 11, 2023, https://www.medicalnewstoday.com/articles/323465.Depression: What You Need to Know." Medical News Today. Accessed May 11, 2023, https://www.medicalnewstoday.com/articles/156285.Cognitive Behavioral Therapy: What You Need to Know." Medical News Today. Accessed 11 May 2023. www.medicalnewstoday.com/articles/145855.Support the showFollow us on: https://www.instagram.com/allblackmenneedtherapy/

In late November 1989, college freshman Mandy Stavik returned to her hometown of Acme, Washington to celebrate the holidays with her family. On the afternoon of November 24, the day after Thanksgiving, Mandy told her family she was going for a run. When she still hadn't returned that evening, her mother became concerned and called around to her friends, but none had heard from her. When she still hadn't returned the next morning, the panic set in, and the search began.For three days, the residents of Acme, Washington undertook an increasingly desperate search for Mandy Stavik and were heartbroken when her body was eventually located in the shallow water of the Nooksack River. Local police began an intense investigation, but after months of dead ends and dwindling leads, the case wound down and eventually went cold.Mandy Stavik's death would likely have remained unsolved, were it not for a tenacious cold case detective, who in 2009 began running old DNA samples against samples collected from suspects over the last two decades.Thank you to the fantastical David White for research assistanceReferencesAssociated Press. 1989. "Amanda Stavik's brother also died tragically." Lewiston Tribune, December 1.Ferm, Carol. 1989. "A flood of memories, a torrent of tears." The Bellingham Herald, December 3: 1.—. 1989. "Community's sense of peace is shattered." The Bellingham Herald, November 29: 1.—. 1989. "Family and friends keep a vigil of hope." The Bellingham Herald, November 26: 11.—. 1989. "Loss angers, saddens classmate." The Bellingham Herald, November 29: 2.—. 1989. "Reward offered." The Bellingham Herald, November 27: 1.—. 1989. "Teen presumed kidnapped." The Bellingham Herald, November 26: 1.Ferm, Carol, and Cathy Logg. 1989. "Search for missing teen continues." The Bellingham Herald, November 27: 1.—. 1989. "Stavik's body found in Nooksack." The Bellingham Herald, November 28: 1.Logg, Cathy. 1989. "Clues elusive in Stavki's death." The Bellingham Herald, November 29: 1.—. 1989. "Investigators get many tips in Stavik case." The Bellingham Herald, December 1: 13.—. 1989. "Police issue a warning about human predators." The Bellingham Herald, December 20: 11.—. 1989. "Sheriff seeks pudgy-faced man for questioning in Stavik case." The Bellingham Herald, December 3: 13.—. 1990. "Stavik case awaits tests." The Bellingham Herald, March 20: 1.—. 1992. "Stavik 'suspect' files suit." The Bellingham Herald, March 21: 1.—. 1990. "Garment ID'd tentatively as Mandy's." The Bellingham Press, January 28: 15.Mittendorf, Robert. 2017. "Arrest in 1989 killing - sheriff credits DNA." The Bellingham Herald, December 14: A1.Pratt, Denver. 2018. "Defense challenges DNA evidence in '89 slaying." The Bellingham Herald, August 11: A1.—. 2019. "Defense in murder trial opening: 'No one knows what happened to Ms. Stavik'." The Bellingham Herald, May 11: A1.—. 2017. "First-degree murder charge filed in 1989 kiling of Stavik." The Bellingham Herald, December 15: A1.—. 2019. "'I wanted to do the right thing for Mandy,' Bass' co-worker testifies." The Bellingham Herald, May 17: A1.Sirken, Alec. 2016. How two moms chatting at a water park helped crack a Thanksgiving cold case murder. July 16. Accessed May 18, 2023. https://www.cbsnews.com/news/mandy-stavik-case-how-two-moms-chatting-at-a-water-park-helped-crack-thanksgiving-cold-case-murder/.State of Washington vs. Timothy Bass. 2021. 80156-2-I (The Court of Appeals for the State of Washington, June 1)See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On December 2, 2018, the parents of twenty-one-year-old Grace Millane, a British tourist on vacation in New Zealand, became concerned when the birthday wishes they sent their daughter went unacknowledged. Having completed her degree at the University of Lincoln a few months earlier, Grace had spent several weeks traveling during her gap year but had been keeping in regular contact with her parents since leaving for her trip. When they still hadn't heard from their daughter three days later, Grace's parents called Auckland police and reported her missing. A week later, Grace Millane's body was discovered in a suitcase near an access road in the Waitakere Ranges, a dense wooded area about twelve miles outside Auckland. A day later, investigators arrested twenty-six-year-old Jesse Kempson, who was the last person seen with Grace on the night of the murder when the two were captured together by a CCTV camera going up to Kempson's room at the CityLife Hotel.Please Consider Signing this PetitionThank you to our favorite David White for research assistanceReferencesBBC News. 2018. Grace Millane: Man appears in court charged with backpacker's murder. December 10. Accessed May 3, 2023. https://www.bbc.com/news/uk-england-essex-46502649.Creed, Rebecca. 2021. "Former flatmate of Grace Millane's killer says he was." The Echo, November 15.Critchell, Matthew. 2019. "Backpacker Grace spoke to men on bondage chat rooms,." The Echo, November 20.Emes, Toby. 2019. "Accused killer admitted Grace was dead in second interview." The Echo, November 14.Faulkner, Doug. 2019. Grace Millane murder: A trial that gripped a nation. November 22. Accessed May 2, 2023. https://www.bbc.com/news/uk-england-essex-50515326.Feehan, Katie. 2018. "Brother of Wickford woman missing in New Zealand says lack." The Echo, December 5.—. 2018. "Police release last known image of missing Wickford woman." The Echo, December 6.Graham-Mclay, Charlotte. 2018. "After backpacker's killing, New Zealand looks again at violence against women." New York Times, December 13.—. 2018. "New Zealand murder case leads to rebuke of Google." New York Times, December 15.—. 2018. "New Zealander accused of killing tourist." New York Times, December 9.Humphries, Will, and Bernard Lagan. 2018. "Distraught father flies to join backpacker search." The Times, December 7.Jesse Shane Kempson v. The Queen. 2021. SC 11/2021 NZSC 74 (Supreme Court of New Zealand, June 29).Kirk, Tristan. 2019. "Guilty: Fantasist who killed Grace." London Evening Standard, November 22.—. 2019. "Guilty: Grace jury takes only five hours to return verdict of murder." London Evening Standard, November 22.Kolirin, Lianne. 2020. "Grace Millane's killer attacked other women." The Times, December 22.Lagan, Bernard. 2018. "Body found in search for missing backpacker." The Times, December 10.—. 2019. "British backpacker's 'killer' lied about their Tinder date." The Times, November 13.Lagan, Bernard, and Will Humphries. 2018. "Father appeals for clues to help find missing daughter." The Times, December 8.Leask, Anna. 2020. Who is Grace Millane's murderer? Unravelling labyrinth of lies and a fatal Tinder date. February 20. Accessed May 1, 2023. https://www.nzherald.co.nz/nz/who-is-grace-millanes-murderer-unravelling-labyrinth-of-lies-and-a-fatal-tinder-date/PDGHMSM67MZQ5VBH4GT2XIXZ7Q/?c_id=1&objectid=12287282.MacDonald, Stuart. 2021. "'Rough sex' defence for murder could be banned." The Times, May 29.Roy, Eleanor Ainge. 2019. "Grace Millane trial: blood in hotel room likely backpacker's." The Guardian, November 8.—. 2019. "Grace Millane trial: witness says she feared she would die." The Guardian, November 11.—. 2019. "'She should have been safe here'." The Guardian, November 22.Smith, Anneka. 2020. "Grace Millane's life: far more than the details of her death." Radio New Zealand, February 21.South Wales Echo. 2020. "Grace's killer 'raped another Brit tourist'." South Wales Echo, December 23.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

On the evening of February 16, 1981, nineteen-year-old Arne Johnson stabbed his friend and landlord Alan Bono to death during an argument, after which Johnson fled the scene and was arrested several miles away later that night. Under normal circumstances, the murder of one man by another in a small town would hardly register on the scale of national, or even regional news, but if Arne Johnson was to be believed, these weren't ordinary circumstances. According to Arne, the devil made him do it.Thank you to Dave White for research assistance.References:Associated Press. 1986. "Man released early in 'demon murder case'." Hartford Courant, January 23: 47.Brozek, Diane. 1981. "Teen-ager charged in 'possession' case." Hartford Courant, March 20: 11.Carl Glatzel Jr. et al v. Gerald Brittle et al. 2010. DBCV-08-4008461-S (Connecticut Superior Court Judicial District of Danbury, October 25).Christoffersen, John. 2007. "Suit vs. psychic says demon murder was a hoax." Record-Journal, October 10: M3.Clendinen, Dudley. 1981. "Defendant in murder puts the devil on trial." New York Times, March 23: B1.Galup. n.d. Religion. Accessed May 10, 2023. https://news.gallup.com/poll/1690/religion.aspx.Harris, John. 1981. "Bizarre happenings surround killing in Brookfield." Hartford Courant, February 27: 2.—. 1981. "Critics bedevil demonolgist, attorney in slaying case ." Hartford Courant, June 22: B1.—. 1981. "'Demon' murder case sent to Danbury jury." Hartford Courant, November 21: 8.—. 1981. "Exorcism, demons' role argued." Hartford Courant, March 15: 1.—. 1981. "Johnson guilty in demons case." Hartford Courant, November 25: 1.—. 1981. "Judge bars demonic possession defense." Hartford Courant, October 29: 1.Healion, James. 1981. "A barmaid testified Thursday that murder suspect Arne Cheyenne..." United Press International, November 5.—. 1981. "A judge Wednesday threw out the 'demon defense'." United Press International, October 28.—. 1981. "Judge Robert J. Callahan Thursday refused to reconsider his decision." United Press International, October 29.—. 1981. "The murder trial of Arne Cheyenne Johnson in Danbury." United Press International, November 13.Pionzio, Melissa. 2007. "'Factual' exorcism book evokes past pain." Hartford Courant, October 14: B1.Putcamp, Luise. 1981. "Supernatural episodes form prelude to killing." Buffalo Evening News, July 30: 1.—. 1981. "Suspect's alibi: He was possessed." Buffalo Evening News, August 5: 2.Stagis, Julie. 2014. "Killer's defense: He was possessed." Hartford Courant, April 22: B1.2006. A Haunting. Directed by Stuart Taylor. Produced by Tom Naughton.United Press International. 1981. "'Demon slayer' gets 10-to-20 year sentence." United Press International, December 18.United States Conference of Catholic Bishops. n.d. Exorcism. Accessed May 8, 2023. https://www.usccb.org/prayer-and-worship/sacraments-and-sacramentals/sacramentals-blessings/exorcism.Walzer, E.B. 1982. "Appeal dropped in 'demon' case." The Reporter Dispatch, March 19: 2.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The murder of Solomon P. Sharp by Jereboam Beauchamp is known as The Kentucky Tragedy. It's a complicated story of seduction, politics, love and execution.  Want more Southern Mysteries?  Hear the Southern Mysteries show archive of 60+ episodes along with Patron exclusive podcast, Audacious: Tales of American Crime and more when you become a patron of the show. You can immediately access exclusive content now at patreon.com/southernmysteries Connect Website: southernmysteries.com Facebook: Southern Mysteries Podcast Twitter: @southernpod_ Instagram: @shannonballard_ Email: southernmysteriespodcast@gmail.com    Episode Sources Southern Literary Messenger. Encyclopedia of Virginia. Accessed May 30, 2023. https://encyclopediavirginia.org/entries/southern-literary-messenger/ The confession of Jereboam Beauchamp "(written by himself) who was executed at Frankfort, Ky., for the murder of Col. Solomon P. Sharp, a member of the legislature, and late attorney-general of Ky. To which is added some poetical pieces written by Mrs. Ann Beauchamp, who voluntarily put a period to her existence on the day of the execution of her husband, and was buried in the same grave with him. Accessed May 30, 2023. https://digital.library.cornell.edu/catalog/sat1109 The Kentucky Tragedy in American Literature: From Thomas Holley Chivers to Robert Warren. Jack Edward Surrency, University of Tennessee, Knoxville. Accessed May 30, 2023. ttps://trace.tennessee.edu/cgi/viewcontent.cgi?article=5389&context=utk_graddiss Jereboam O. Beauchamp. Murderpedia. Accessed May 29, 2023. https://murderpedia.org/male.B/b/beauchamp-jereboam.htm Episode Music I Am A Man Who Will Fight For Your Honor by Chris Zabriske and No. 7 Alone with My Thought by Esther Abrami. Licensed under Creative Commons; Theme Song “Dark & Troubled” by Pantherburn. Special thanks to Phillip St Ours for permission for use

A little after 10:00 pm on the evening of May 1, 1990, Pamela Smart returned home from work to find her husband, twenty-four-year-old Gregg Smart, lying dead just beyond the front door of their condominium, a single bullet hole in his head. Detectives from the small town of Derry, NH arrived to find what appeared to be the scene of a robbery; though, very little looked to have been stolen and to investigators the scene felt staged. Two days later, Derry Police Captain Loring Jackson announced that Gregg Smart's death wasn't a random attacked, he'd been murdered by someone who knew him. The murder of Gregg Smart, and the trial that followed, shocked the population of New Hampshire, where it remains perhaps the most notorious criminal trial in the state's history. As the first criminal trial to be televised from beginning to end, the case of Pamela Smart and her teenage lover captivated a national audience, leading to television and feature films, several nonfiction books, and countless television specials in the decades that followed.Special thank you to the brilliant David White for research assistanceReferencesBaker, Frank. 1990. "Smart to be jailed until trial." Concord Monitor, August 14: 1.—. 1990. "Widow charged as accomplice." Concord Monitor, August 2: 14.Carton, Barbara. 1991. "The Pamela Smart story." Boston Globe, Marcg 21.1991. NH v. Smart: Opening Statements. Directed by Court TV. Performed by Court TV.Derry News. 1990. "Family and friends puzzle over murder." Derry News, May 4: 1.Englade, Ken. 1991. Deadly Lessons. New York, NY: St. Martin's Press.Gaines, Judith, and Alexander Reid. 1991. "Jurors say tales a key to their decision." Boston Globe, March 23: 1.Hernandez, Monica. 2023. Accomplice in Smart murder asks for sentence reduction. January 10. Accessed May 1, 2023. https://www.wmur.com/article/smart-murder-vance-lattime-sentence-reduction/42449265.Hohler, Bob. 1991. "3 guilty in N.H. killing." Boston Globe, January 30: 1.—. 1991. "Confidant was wired by police." Boston Globe, March 15: 21.—. 1991. "Smart is found guilty." Boston Globe, March 23: 1.—. 1991. "Smart pleaded for life, N.H. teen-ager testifies." Boston Globe, March 6: 19.—. 1991. "Tales of seduction." Boston Globe, March 12: 1.—. 1990. "Tape offered at Smart hearing." Boston Globe, August 14.—. 1991. "Witness: Smart asked for tips on reaction." Boston Globe, March 3: 27.—. 1991. "Youth says blood flowed, tears did not." Boston Globe, March 13: 35.Kilgannon, Corey. 2023. "Smart, who plotted with a teen lover to kill her husband, loses a parole bid." New York Times, March 30.Kittredge, Clare. 1991. "A verdict to take to son's grave." Boston Globe, March 23: 1.—. 1991. "Smart trial garners big TV audience." Boston Globe, March 17: 1.Richardson, Franci. 1990. "Mrs. Smart absolutely convinced husband surprised thief." Derry News, May 9: 1.Sawicki, Stephen. 1991. Teach Me to Kill: The Shocking True Story of the Pamela Smart Murder Case. New York, NY: Avon Books.Schweitzer, Sarah. 2015. "5 years later, shooter to go free: William Flynn was 16 when he was lured into murder by Pamela Smart." Boston Globe, March 13: A1.State of New Hampshire v. Pamela Smart. 1993. 622 A.2d 1197 (Supreme Court of New Hampshire, February 26).Wang, Beverley. 2005. "Pamela Smart accomplice released." Concord Monitor, June 15: 10.West, Nancy. 2016. Breaking Silence: Cecelia Pierce Speaks. October 12. Accessed April 24, 2023. https://www.nhmagazine.com/breaking-silence-cecelia-pierce-speaks/.West, Nancy, and David Mendelsohn. 2016. Pamela Smart: innocent of (still) guilty. October 13. Accessed April 29, 2023. https://www.nhmagazine.com/pamela-smart-innocent-or-still-guilty/ https://www.bostonherald.com/2015/03/09/brother-of-pamela-smarts-victim-killer-did-his-time/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Mention the Pamela Smart case to someone in New Hampshire, and they'll know exactly what you're talking about. The case captivated the nation in the early 90's and at the center of it all, of course, was Pamela. A New Hampshire native, she had big dreams of becoming somebody and making a name for herself. She moved away from her small town and almost did, but in the name of love she moved back home and settled into her career as a School Administrator. It was via that position that she would meet young sophomore in High School, Billy Flynn. Pam groomed the boy, and had him thinking they were fully in love before she asked him a question that would change both of their lives forever: Would he murder her husband? In part one we'll cover the early life of both Pam and her husband, Gregg Smart, we'll break down how Pam and Billy became involved with each other and just how Pam got Billy to believe that murdering her husband was what it would take for them to be together forever.Special thank you to the brilliant David White for research assistanceReferencesBaker, Frank. 1990. "Smart to be jailed until trial." Concord Monitor, August 14: 1.—. 1990. "Widow charged as accomplice." Concord Monitor, August 2: 14.Carton, Barbara. 1991. "The Pamela Smart story." Boston Globe, Marcg 21.1991. NH v. Smart: Opening Statements. Directed by Court TV. Performed by Court TV.Derry News. 1990. "Family and friends puzzle over murder." Derry News, May 4: 1.Englade, Ken. 1991. Deadly Lessons. New York, NY: St. Martin's Press.Gaines, Judith, and Alexander Reid. 1991. "Jurors say tales a key to their decision." Boston Globe, March 23: 1.Hernandez, Monica. 2023. Accomplice in Smart murder asks for sentence reduction. January 10. Accessed May 1, 2023. https://www.wmur.com/article/smart-murder-vance-lattime-sentence-reduction/42449265.Hohler, Bob. 1991. "3 guilty in N.H. killing." Boston Globe, January 30: 1.—. 1991. "Confidant was wired by police." Boston Globe, March 15: 21.—. 1991. "Smart is found guilty." Boston Globe, March 23: 1.—. 1991. "Smart pleaded for life, N.H. teen-ager testifies." Boston Globe, March 6: 19.—. 1991. "Tales of seduction." Boston Globe, March 12: 1.—. 1990. "Tape offered at Smart hearing." Boston Globe, August 14.—. 1991. "Witness: Smart asked for tips on reaction." Boston Globe, March 3: 27.—. 1991. "Youth says blood flowed, tears did not." Boston Globe, March 13: 35.Kilgannon, Corey. 2023. "Smart, who plotted with a teen lover to kill her husband, loses a parole bid." New York Times, March 30.Kittredge, Clare. 1991. "A verdict to take to son's grave." Boston Globe, March 23: 1.—. 1991. "Smart trial garners big TV audience." Boston Globe, March 17: 1.Richardson, Franci. 1990. "Mrs. Smart absolutely convinced husband surprised thief." Derry News, May 9: 1.Sawicki, Stephen. 1991. Teach Me to Kill: The Shocking True Story of the Pamela Smart Murder Case. New York, NY: Avon Books.Schweitzer, Sarah. 2015. "5 years later, shooter to go free: William Flynn was 16 when he was lured into murder by Pamela Smart." Boston Globe, March 13: A1.State of New Hampshire v. Pamela Smart. 1993. 622 A.2d 1197 (Supreme Court of New Hampshire, February 26).Wang, Beverley. 2005. "Pamela Smart accomplice released." Concord Monitor, June 15: 10.West, Nancy. 2016. Breaking Silence: Cecelia Pierce Speaks. October 12. Accessed April 24, 2023. https://www.nhmagazine.com/breaking-silence-cecelia-pierce-speaks/.West, Nancy, and David Mendelsohn. 2016. Pamela Smart: innocent of (still) guilty. October 13. Accessed April 29, 2023. https://www.nhmagazine.com/pamela-smart-innocent-or-still-guilty/ https://www.bostonherald.com/2015/03/09/brother-of-pamela-smarts-victim-killer-did-his-time/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The story of Joe Ball has been a part of Texas lore since the 1930s. He's known to have killed two people but investigators believed he may have killed up to 20. Were nearly a dozen victims fed to Joe's pet alligators?   Want more Southern Mysteries?  Hear the Southern Mysteries show archive of 60+ episodes along with Patron exclusive podcast, Audacious: Tales of American Crime and more when you become a patron of the show. You can immediately access exclusive content now at patreon.com/southernmysteries   Connect Website: southernmysteries.com Facebook: Southern Mysteries Podcast Twitter: @southernpod_ Instagram: @shannonballard_ Email: southernmysteriespodcast@gmail.com    Episode Sources Joe Ball: The Butcher of Elmendorf. Accessed May 1, 2023. https://web.archive.org/web/20070916033830/http://www.crimelibrary.com/serial_killers/history/joe_ball/index.html Two Barmaids, Five Alligators, and the Butcher of Elmendorf. Accessed May 4, 2023. https://www.texasmonthly.com/true-crime/butcher-of-elmendorf-alligators/ Joseph D. Ball Accessed May 1, 2023. http://murderpedia.org/male.B/b/ball-joseph.htm   Episode Music Lost Cowboy by Kevin MacLeod. Licensed under Creative Commons; Theme Song “Dark & Troubled” by Pantherburn. Special thanks to Phillip St Ours for permission for use